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resumo 
 
Introdução: O aumento da resistência aos antimicrobianos atuais está 
a criar a necessidade para o desenvolvimento de novos agentes 
antimicrobianos, aos quais os micro-organismos não desenvolvam 
resistência facilmente. Nanopartículas parecem ser uma boa aposta 
nesta luta contra micro-organismos. De facto, tem-se verificado que 
diversos tipos de nanopartículas com base de metal, como prata, cobre 
e zinco, possuem atividade antimicrobiana. Apesar de a prata ter vindo 
a exibir maior atividade antimicrobiana, este elemento não faz parte da 
homeostase humana e apresenta algum potencial para citotoxicidade, 
sendo também mais caro que cobre e zinco. Estes, ainda que menos 
eficazes, são bons candidatos para a produção de baixo custo de 
nanopartículas com atividade antimicrobiana. 
 
Objectivo: Desenvolver estratégias de síntese de baixo custo para a 
produção de nanopartículas de cobre e de zinco com actividade 
antimicrobiana. 
 
Métodos: Síntese pelo aumento do pH de uma solução contendo cobre 
(II) ou zinco (II) e ligando(s), pela adição de uma base como hidróxido 
de sódio (NaOH). Modificações a este método foram feitas para a 
obtenção de diferentes fases minerais. As nanopartículas foram 
caracterizadas usando ICP-OES, DLS e XRD. A actividade 
antibacteriana foi determinada usando o método de micro-diluição em 
broth, usando placas de 96 poços. 
 
Resultados e discussão: Nanopartículas de cobre (oxo-hidróxidos, 
óxidos, fosfatos) foram sintetizadas usando diversos ligandos e 
diferentes condições de síntese. Estas nanopartículas eram instáveis 
quando diluídas em broth. Apesar de um aumento da atividade 
antimicrobiana ter sido obtida, é necessário um aperfeiçoamento para 
que estes materiais sejam viáveis como antimicrobianos. 
Nanopartículas de zinco obtidas usando cisteína como ligando não 
inibiram o crescimento bacteriano. 
 
Conclusão: Nanopartículas de diferentes composições e carga de 
superfície foram obtidas. Em alguns casos, houve um aumento da 
estabilidade e atividade antimicrobiana das nanopartículas de cobre em 
relação a trabalhos anteriores. As nanopartículas de zinco obtidas não 
inibiram o crescimento bacteriano. 
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abstract 
 
Introduction: The growing resistance to current antimicrobials is 
creating the need for novel antimicrobial agents, to which 
microorganisms will not easily develop resistance. Nanoparticles seem 
to be a valuable option in this fight against microorganisms and 
antimicrobial activity has been reported for several types of metal-
based nanoparticles, such as silver, copper and zinc. Although silver 
has been shown to have higher antimicrobial activity, this element is 
not part of the homeostasis of humans and presents some potential for 
cytotoxicity. It is also more expensive than copper and zinc. These 
although less effective, are good candidates for the cheap production 
of nanoparticles with antimicrobial activity. 
 
Aim: To develop cheap synthetic strategies for the production of 
copper and zinc nanoparticles with antimicrobial activity. 
 
Methods: Synthesis by increasing the pH of a solution containing 
copper (II) or zinc (II) and ligand(s), by adding a base such as sodium 
hydroxide (NaOH). Modifications to this method were made in order to 
obtain nanoparticles of a different mineral phase. The nanoparticles 
were characterised using ICP-OES, DLS, and XRD. The antibacterial 
activity was tested using the method of microdilution in broth, using 
96-well plates. 
 
Results and discussion: Copper-based nanoparticles 
(oxo-hydroxides, oxides, phosphates) were synthesised using different 
ligands and different conditions of synthesis. These nanoparticles were 
unstable when diluted in broth. An increase in the antimicrobial activity 
was achieved, but further improvements are still required to make 
these materials viable antimicrobials. Zinc nanoparticles showed poor 
antibacterial activity. 
 
Conclusion: Nanoparticles of different compositions and surface 
charge were obtained. There was improvement in the stability and 
antibacterial activity of copper based nanoparticles in relation to 
previous work. Zinc nanoparticles did not inhibit bacterial growth. 
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1. INTRODUCTION 
 
In the last century, antimicrobials have been developed and successfully used, 
however, their continuous usage led to the development of resistance by microorganisms. 
(e.g. bacterial resistance to antibiotics). Although most of the existing antibiotics can still fight 
drug-resistance bacteria, their effectiveness is decreasing [1]. Due to this problem, attempts 
have been made to develop new and effective antimicrobial agents, to which 
microorganisms will not develop resistance easily.   Nanoparticles, due to their unique 
properties (e.g., large surface area to volume ratio), seem to be a valuable option as 
antimicrobials. In fact, silver nanoparticles have already been used and showed significant 
antimicrobial activity [2], but the cost of this metal limits its use. There are other cheaper 
metals which are known to have antimicrobial activity. For instance, copper has been used 
as a biocide for centuries, and, although its usage as an antimicrobial has decreased in the 
last few centuries, it is rising in prominence as an antimicrobial agent. The use of copper 
surfaces as self-sanitizing material is now encouraged, and many publications deal with the 
mechanistic aspects of contact-mediated killing by copper [3]. Zinc is another metal which 
has antimicrobial properties, and, for example, is added to many oral healthcare  products 
[4]. The use of nanoparticles of copper or zinc may enhance the antimicrobial activity of 
these metals and their use is unlikely to result in development of resistance by bacteria 
because these elements are essential to their metabolism. In this way, nanotechnology 
seems to be useful in this battle against microbes. There are many different ways of 
producing metal nanoparticles, which depend largely on the type of nanoparticles to be 
produced. The production of nanoparticles can be done using chemical methods, which are 
typically cheaper than physical methods and can be readily scaled-up.  
This project is part of an on-going programme to develop cheap synthetic strategies 
for the production of copper and zinc nanoparticles with antimicrobial activity on the same 
range as silver nanoparticles. Therefore, chemical approaches are being employed in this 
project for the production of nanoparticles. For this purpose, different conditions and ligands 
were tested, in order to produce a range of stable copper- and zinc-based nanoparticles. 
Subsequently, the antibacterial activity of the obtained nanoparticles was also tested.  
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2. BACKGROUND 
 
2.1. BACTERIA 
 
Bacteria are prokaryotes and are surrounded by a rigid cell wall composed of 
polysaccharides and peptides. Beneath the cell wall is the plasma membrane, which is a 
bilayer of phospholipids and associated proteins. The cell wall is readily penetrated by 
several molecules, but the plasma membrane provides the functional separation between 
the inside of the cell and its external environment. The genetic material is localized in a 
discrete region, the nucleoid, and is not separated from the surrounding cytoplasm by 
membranes. Ribosomes and inclusion bodies are scattered in the cytoplasmic matrix. They 
can also have flagella, which are used for locomotion [5]. 
The structure of the cell wall is unique in nature and is composed of disaccharide-
pentapeptide subunits. The disaccharides N-acetylglucosamine (NAG) and N-acetylmuramic 
acid (NAM) are alternating sugars, with a four amino acid chain linked to the carboxyl group 
of NAM (Fig. 1). Polymers of these subunits crosslink one another via peptide bridges to 
form peptidoglycan sheets. Layers of these sheets are, in turn, crosslinked with one another 
to give a multi-layered, crosslinked structure of considerable strength [6]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 – Structure of a subunit of peptidoglycan, containing N-acetylglucosamine (NAG), N-acetylmuramic acid 
(NAM), and four amino acids. The structure is the one found in most gram-negative bacteria. In some bacteria, 
other amino acids are present [7]. 
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Bacteria can be divided in two major groups: gram-positive and gram-negative. This 
division results from the different responses of bacteria to the Gram-stain procedure. Gram-
positive bacteria stain purple, whereas gram-negative bacteria are coloured pink or red by 
the technique.  This different staining results from structural differences in the cell wall of 
both types of bacteria. The gram-positive cell wall consists of a single homogeneous 
peptidoglycan or murein layer. In contrast, the gram-negative cell wall is quite complex. It 
has a peptidoglycan layer surrounded by a thick outer membrane (Fig. 2) [8]. This outer 
membrane functions as the cell‟s initial barrier to the environment. 
The components of the cell surface are comprised of macromolecules containing 
carboxylate, phosphate, and amino groups which are ionized as a function of the 
environmental pH, thereby conferring electrostatic charge to the cell surface. Bacterial cells 
possess a net negative electrostatic surface charge when cultivated at physiological pH 
values [9]. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 – Structure of the cell wall from both gram-positive and gram-negative bacteria [8]. 
 
Bacteria need specific conditions to grow; they need nutrients to take energy from 
and to act as the cellular building components. They also need carbon, hydrogen, oxygen, 
nitrogen, sulphur, phosphorus, and other inorganic micronutrients. Growth can be defined as 
an increase in cellular components. This may result in the increase of the microorganism‟s 
size and/or number of cells. It is difficult to study the growth and reproduction of individual 
microorganisms, especially due to their small size and, thus, for studying the growth, 
normally the changes in the total population are followed [8]. The life of a bacterial cell can 
be seen as “feast or famine”. This model comes up because, besides the ability of bacteria 
to consume virtually all readily metabolizable nutrients in the environment, they can also 
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persist for long periods of time under starvation conditions once the nutrients have been 
depleted [10].  
For microbiological studies, there is a need to grow and maintain microorganisms in 
the laboratory, and this is only possible if suitable media are available. A culture medium is a 
solid or liquid preparation used to grow, transport and store microorganisms [8].  There is a 
classification for media types: defined media and complex media. In defined media, the 
exact composition is known in both a qualitative and a quantitative sense. However, the 
culture of many microorganisms does not require the knowledge of the exact composition of 
the medium. In these cases, complex media can be used. Complex media are made up of 
digests of microbial, animal or plant products. These digests are commercially available in 
dehydrated form and can be easily prepared [7]. Most heterotrophic bacteria would be 
routinely grown on such a medium. If a complex medium is in liquid form, it is called broth. 
When growing bacteria on a solid medium, a solidifying agent, such as agar, is added to the 
medium [11]. 
The growth of the population can be studied by analysing the growth curve of a 
microbial culture. When microorganisms are cultivated in liquid medium, they usually are 
grown in a batch culture or closed system. This means that no fresh medium is provided 
during incubation, leading to a decline in the concentration of nutrients and to an increase in 
the concentration of waste residues. Therefore the organisms cannot grow exponentially 
indefinitely [8]. The resulting growth curve of a microbial culture has four distinct phases: lag 
phase, exponential (log) phase, stationary phase, and death phase (Fig. 3). When 
microorganisms are inoculated into a fresh medium, usually the growth only starts after a 
period of time, the lag phase. The length of this period may vary, depending on the condition 
of the microorganisms and the conditions of growth. For example, this phase will be longer if 
the inoculum is from an old culture rather than young one. In the exponential phase, the 
microorganisms grow and divide at the maximum rate. The rate of exponential growth is 
constant and may vary greatly. It is influenced not only by the environment conditions and 
the nature of the culture medium but also by the genetic characteristics of the organism 
itself. The stationary phase results from the ceasing of the bacterial growth.  This phase is 
usually reached by bacteria at a population level of around 106 cells per ml, but the final 
population size depends on several factors, such as nutrient availability and the type of 
microorganism. Generally, a microorganism culture enters the stationary phase due to the 
depletion of nutrients and/or the accumulation of waste residues that inhibit growth. The 
growth rate in this case is zero. The building up of toxic wastes and depletion of nutrients 
leads eventually to the death phase, where cells have lost their viability. The death of the 
population is constant like in the exponential phase, but typically the rate of death is much 
slower. In some cases cell death is accompanied by cell lysis. When cells fail to lyse, the 
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death rate may appear less pronounced when using turbidimetric assays [7, 8]. A fifth phase 
can be considered, the long-term stationary phase. After death, E. coli for example can be 
maintained in batch culture for longer periods of time without adding more nutrients. These 
can be done by adding distilled water to maintain the volume and osmolarity. Cultures can 
be maintained at densities of ~106 colony forming units (CFU) per ml for more than 5 years 
in these conditions. In this case, the growth and death are balanced and the growth rate is 
stationary [12].  
 
 
 
 
 
 
 
 
 
 
Fig. 3 – Typical growth curve for a bacterial population. A viable count measures the cells in the culture that are 
capable of reproducing. Optical density (turbidity), a quantitative measure of light scattering by a liquid culture, 
increases with the increase in cell number [7]. 
 
2.2. ANTIMICROBIALS 
 
Antimicrobials are natural or synthetic chemicals that kill or inhibit the growth of 
microorganisms. Antibacterial agents can be classified as bactericidal, bacteriolytical, and 
bacteriostatic. Bactericidal agents kill the cell but do not destroy it. Thus, the total number of 
cells remains constant (Fig. 4A). Bactericidal agents can also be bacteriolytical, i.e. they can 
kill by cell lysis, leading to the release of the cytoplasmic contents. This means that not only 
the viable cell number decreases but also the total cell number (Fig. 4B). Bacteriostatic 
agents do not kill the organism and the number of viable cells remains constant (Fig. 4C) [7]. 
 
 
 
 
 
 
Fig. 4 – Curves of bacterial growth in the presence of bactericidal (A), bacteriolytical (B), and bacteriostatic (C) 
agents. The arrow represent the time at which the agent was added, during the exponential growth [7]. 
C B A 
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There are several possible strategies for antimicrobial therapeutics, but the most 
common against bacteria is the use of antibiotics. Different types of antibiotics have different 
targets, thus having different mechanisms of action. Although most antibiotics are effective 
at treating their target infections, some bacterial resistance has developed over the last 
decades. This poses as a serious problem in public health, as it results in treatment failure 
and it may also lead to infection control problems, either within healthcare institutions or the 
community [13].  Thus, there is a need to find other antibacterial therapeutics based on 
different mechanisms of action, to which bacterial resistance is less likely to be developed. 
Nanoparticles have shown antimicrobial activity, which has been reported over the past few 
years, and that makes them one possible option [13]. Nevertheless, before developing 
nanoparticulate strategies, it is important to understand the mechanism of action and of 
resistance to antibiotics. 
There are four major modes of antibacterial action of antibiotics: (1) interference with 
cell wall synthesis; (2) inhibition of protein synthesis; (3) interference with nucleic acid 
synthesis; and (4) inhibition of a metabolic pathway [14].  
Bacteria may develop resistance to antibacterial drugs through various mechanisms. 
Some species of bacteria are innately resistant to one or more classes of antimicrobial 
agents. A far more alarming problem, acquired resistance, is where initially susceptible 
populations of bacteria become resistant to an antibacterial agent and proliferate under the 
selective pressure of the use of that agent [13]. The mechanisms through which bacteria 
develop resistance to antimicrobials have their origins at the genetic level. The resistance 
can be a result of chromosomal mutation or inductive expression of a latent chromosomal 
gene or by exchange of genetic material through transformation (exchange of DNA), 
transduction (bacteriophage), or conjugation by plasmids (extrachromosomal DNA) [15]. 
Thus, normally susceptible populations of bacteria may become resistant to antimicrobial 
agents through mutation and selection, or by acquiring the genetic information that encodes 
the resistance (horizontal evolution) from other bacteria. Spontaneous mutation (Fig. 5) may 
cause resistance by: (1) changing the target protein to which the antibacterial agent binds or 
by modifying or eliminating the binding site; (2) by upregulating the production of enzymes 
that inactivate the antimicrobial agent; (3) downregulating or altering an outer membrane 
protein channel that the drug requires for cell entry; or (4) upregulating pumps that expel the 
drug from the cell [13]. Mutation and selection enable many bacterial species to adapt 
quickly to the introduction of antibacterial agents into their environment.  
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Fig. 5 - Main mechanisms by which spontaneous mutation results in antimicrobial resistance: altered target site, 
enzymatic inactivation or modification, decreased penetration, and increased efflux [16].  
 
 
2.2.1. Nanoparticles as antimicrobials 
 
Materials at the nanoscale are now seen as good antimicrobial agents due to their 
high surface area to volume ratio, thus having unique chemical and physical properties [17, 
18]. Metallic nanoparticles are more promising with regards to antimicrobial activity due to 
their large surface area to volume ratio. Some nanoparticles of different metals display 
antibacterial activity and are used for various healthcare, hygiene and personal care 
purposes (e.g. silver, copper and zinc) [19, 20].  
The interactions between metal nanoparticle and bacterium appear to be based on 
contact-mediated membrane lipid peroxidation by reactive oxygen species (ROS) production 
and, in the case of nanoparticles, are enhanced by a greater contact with the membrane due 
to their large surface area. The contact is facilitated by electrostatic forces between 
nanoparticles and bacteria [19]. Nanoparticles also cause the accumulation of envelope 
protein precursors, which seems to destabilize the outer cell wall and results in the collapse 
of the plasma membrane. This is probably due to the dissipation of the proton motive force, 
resulting in the depletion of intracellular ATP, which is needed for the translocation of newly 
synthesized bacterial envelope membrane proteins by preprotein translocase [21]. 
Nanoparticles can also be taken up by the bacterium. Once they are internalized they tend to 
react with sulphur-containing proteins as well as with phosphorus-containing compounds 
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such as DNA [17]. The antibacterial action of the nanoparticles can also be due to the 
release of ions by the nanoparticle. These ions can then pass the bacterial cell wall and 
reach the cytoplasm, where they will induce the production of ROS and interact with cellular 
components, such as proteins and DNA [18]. The bactericidal properties of nanoparticles are 
size dependent as shown by a study on the determination of the effect of silver nanoparticles 
with sizes between 1-100 nm on gram-negative bacteria. In this case, only the particles with 
a diameter between ~1-10 nm presented a direct interaction with bacteria. Also, it has been 
shown that silver nanoparticles of smaller size show a stronger antibacterial activity possibly 
due to their higher surface area to volume ratio [17]. Since nanoparticles interact mostly with 
the cell membrane, causing its disruption, bacteria are unlikely to develop mechanisms of 
resistance for the nanoparticles. 
Silver nanoparticles, in particular, have shown to be efficacious against bacteria, 
viruses and other microorganism. It has been shown that silver nanoparticles can have a 
bacterial MIC as low as 6 ppm [22]. Thus, silver nanoparticles have been applied in a wide 
range of applications from disinfecting medical devices and home appliances to water 
treatment. Additionally, silver nanoparticles have been used in the preparation of silver 
nanocomposite fibers, in which the nanoparticles are incorporated inside the fabric [2]. There 
are some disadvantages associated to the use of silver nanoparticles as antimicrobials: (1) 
they are unstable under light and heat conditions; (2) they can interact with Cl- ions in 
aqueous medium, which makes the Ag+ ions lose antibacterial activity; (3) silver is a noble 
metal and is very expensive [23]. Also, silver nanoparticles have been shown to be cytotoxic 
and genotoxic for several human cell lines, and it has been demonstrated that silver 
nanoparticles induce apoptosis in fibroblast cells via the mitochondrial pathway. This may be 
due to the disruption of the mitochondrial respiratory chain by the nanoparticles, leading to 
production of reactive oxygen species and interruption of ATP synthesis, which in turn cause 
DNA damage [24]. In humans, the long-term exposure to silver compounds can cause 
irreversible skin discoloration or Argyria. The exposure limit to soluble silver recommended 
by the Health and Safety Executive is 0.01 mg.m-3 [25]. 
Similarly to silver, copper and zinc nanoparticles also show antimicrobial activity. 
These elements are part of the homeostasis of eukaryotic organisms and therefore, in 
principle, these are likely to be safer than silver nanoparticles. The exposure limit to fumes of 
copper and zinc by the Health and Safety Executive is 1 mg.m-3 for both [25]. However, 
copper and zinc nanoparticles appear to have lower antimicrobial activity than silver 
nanoparticles, but their lower toxicity and their lower cost may offset this disadvantage. 
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2.3. COPPER 
 
Copper is a transition metal with partially filled d orbitals and is the strongest Lewis 
acid in Group IB of the periodic table, which gives copper the ability to mediate electron 
transport, accepting and donating electrons.  Copper exists primarily in one of two oxidation 
states: the oxidized Cu(II) cupric form and the reduced Cu(I) cuprous form. Cu(I) and Cu(II) 
are the most effective monovalent and divalent ions, respectively, for binding to organic 
molecules and possess almost equal tendencies to form complexes with many organic 
ligands [26]. Cu(I) is a closed shell 3d10 transition metal ion and hence diamagnetic. As a 
soft Lewis acid, it tends to bind to soft bases such has thiols, hydrides, alkyl groups, cyanide, 
and phosphines. Cu(II) has a 3d9 configuration and is paramagnetic. As an intermediate 
Lewis acid it forms complexes with additional ligands to Cu(I), including sulphate and nitrate 
[27]. Copper is usually bound to proteins via cysteine, methionine, or histidine amino acid 
side chains [28]. 
 
2.3.1. Copper uses 
 
Human civilization has been using copper for some millennia. Copper was always 
used in a medical way at different levels: for the treatment of headaches, burns, intestinal 
worms, and ear infections and for hygiene in general. Copper can be used as an alternative 
to antibiotics, using copper surfaces in hygiene-sensitive areas. For instance, the idea of 
using copper vessels to render drinkable water has been revived as a low-cost alternative for 
developing countries [3]. It seems to be a good alternative to antibiotics, because, in contrast 
to the highly resistant microbes that have evolved to antibiotics in less than 50 years of use, 
tolerant microbes to copper are extremely rare, a surprising fact, given copper‟s ubiquitous 
presence. This may be due to the essentiality of copper to most microorganisms. Viruses do 
not have tolerance and repair mechanisms as bacteria and fungi and thus are highly 
susceptible to copper induced damage [29].  
However, copper is not appropriate for use for systemic applications (e.g. oral, 
intravenous), mainly since once copper is ingested it readily interacts with transport proteins 
as well as small molecular weight ligands, making it unavailable as an antimicrobial for these 
applications. Furthermore, in cases where no copper excretion pathways are available, the 
unligated free copper in the body may be involved in diseases pathogenesis, such as in 
Alzheimer‟s disease [29]. 
 
10 
 
2.3.2. Homeostasis in bacteria 
 
Although essential to the correct function of eukaryotic and prokaryotic cells, high 
concentrations of copper are toxic. Copper is therefore an essential and a toxic element at 
the same time, and the viability of cells depends on a perfect regulation of transport, storage 
and distribution of this metal. Usefully, for antibacterial applications, the tolerance of 
eukaryotic cells is generally greater than that of prokaryotic. This may be due to the 
existence of metallothioneins (cytoplasmic metal-binding proteins), that can protect cells 
against the toxic effects of copper by chelating this heavy metal. Genes encoding 
metallothioneins occur in animals, higher plants, and eukaryotic micro-organisms but only in 
some prokaryotes [30], such as Synechococcus (Cyanobacteria), Enterobacteriacea, and 
Gammaproteobacteria (Proteobacteria) and Mycobacterium (Actinobacteria) [31]. 
Copper ions are essential for bacteria but can cause a number of toxic cellular effects 
if levels of free ions are not controlled. Thus, bacteria must achieve precise copper 
homeostasis to avoid copper-mediated toxicity whilst maintaining a supply of copper for 
copper-requiring proteins. Bacteria developed a range of mechanisms to protect themselves 
from the toxic effects of copper ions in low concentrations: extracellular sequestration of 
copper ions, relative impermeability of the outer and inner bacterial membranes to copper 
ions, metallothionein-like copper-scavenging proteins in the cytoplasm and periplasm, and 
active extrusion of copper from the cell [3]. The way in which bacteria meet the conflicting 
demands imposed by copper varies depending upon environmental conditions, their adopted 
ecological niche, and phylogeny.  
Thus, copper homeostatic systems have been studied in great detail. Escherichia 
coli, which is a gram negative bacterium and a facultative aerobe, is particularly well studied. 
It lives in the digestive tract of warm-blooded animals. The concentration of copper can be 
high in the digestive tract, particularly in the stomach and duodenum, but even there it 
should not exceed 10 µM. However, it has been shown that under acidic anaerobic 
conditions, which prevail on that part of the digestive tract, copper becomes much more 
toxic. Thus, intestinal bacteria have elaborated mechanisms for copper homeostasis as an 
adaption to their specific ecological niche, the animal gut [32]. Copper enters the bacterial 
cell through an unknown importer (Fig. 6). The responses of E. coli to elevated copper levels 
primarily involve the chromosomally-encoded cue and cus systems. The cus system only 
confers copper-tolerance under extreme copper stress while the cue system is the primary 
copper homeostasis [32]. As extracellular copper levels increase, CueR mediates production 
of a copper-exporting P1B-type ATPase CopA at the cytoplasmic membrane and a 
periplasmic multicopper oxidase CueO – these three proteins constitute the cue system [27]. 
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Although these proteins apparently clear the cytosol of excess of copper, this is retained 
within the periplasm and thus may serve as a compartmentalized store [32]. If copper levels 
keep increasing, expression of the cusCFBA operon is induced by the CusR/S two-
component sensory system, which detects excess of copper in the periplasm, mediating 
export of copper across the outer membrane [27]. The cus system is particularly important in 
providing copper-tolerance under anaerobic conditions [32]. Some E. coli strains also harbor 
the plasmid-borne pco system which involves seven genes, providing further copper-
resistance. The mechanism of copper detoxification provided by this system involves the 
multi-copper oxidase PcoA and its putative partner PcoC, both of which are exported to the 
periplasm [32].  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 - Copper homeostasis mechanisms in E. coli. The most relevant homeostatic systems are shown. CopA is 
a Cu(I)-translocating P-type ATPase, CueO a multi-copper oxidase, and CusCFBA a four-component copper 
efflux pump (regulated by the system CusRS) [33].  
 
2.4. ZINC 
 
Zinc is the first element in group 12 of the periodic table. It has a complete d subshell 
and the divalent cation is the only naturally occurring oxidation state and has no redox 
activity under physiological conditions. Its relative stability, ability to co-ordinate 4 or 
sometimes 6 ligands, and its acid Lewis properties may be fundamental to the biological role 
of zinc [34]. In fact, zinc is the second most abundant trace element in the body, thus being 
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one of the most important trace elements related to health and disease. This element is 
present in all cells and is a requirement for the normal functions of cells, tissues and organs 
of the body. It catalyses enzyme activity, contributes to protein structure, and regulates gene 
expression [35]. 
Zinc (II) is a strong intracellular Lewis acid and is predominantly coordinated to 
proteins via either sulphur “thiol” moieties of cysteine residues or the amino “imidazole” 
ligands of histidine residues [36]. Because of its ability to interact with thiols and block 
essential reactions in the cell, high concentrations of zinc are toxic. Among its many 
applications, zinc materials can also be used as antimicrobials. Some enzyme systems can 
be inhibited by zinc, such as glycolytic enzymes in streptococci. Also, Zn2+ is a well-known 
sulfhydryl reactive agent and many of its antimicrobial actions may be caused by reaction 
with sulfhydryl groups. Due to these antimicrobial properties, zinc is added to many oral 
healthcare products. Usually, zinc is considered more of a bacteriostatic agent rather than a 
bactericidal one. However, it can be used along with other bactericidal agents to increase 
their power [4]. 
 
2.4.1. Homeostasis in bacteria 
 
Prokaryotic organisms do not possess organelles, i.e. sub-cellular compartments, 
thus the major mechanisms that maintain cellular Zn(II) concentrations are limited to the 
highly regulated processes of Zn(II) import, metal sequestration by metallo-chaperones and 
Zn(II) export across the cytoplasmic membrane (Fig. 7) [36]. 
One of the primary mechanisms of Zn(II) import is the ZnuABC, which is a high 
affinity Zn(II) uptake system. This type of transporters usually has two transmembrane 
proteins that form a pore in the membrane allowing the transport of specific substrate from 
one side of the membrane to the other. On the cytosolic membrane face of this pore are one 
or two ATP-binding regions that act to provide the energy for substrate transport from ATP 
hydrolysis. The Znu proteins of E. coli belong to a family of uniquely bacterial divalent metal 
ion ABC transport systems that are dependent upon an extra-cytoplasmic metal-binding 
protein [37]. The ZnuABC system is regulated by Zur, which is a member of the Fur family of 
bacterial metal-responsive regulators and can sense sub-femtomolar concentration of 
cytosolic Zn(II) [38]. In its native state, Zur forms a dimer, which in the presence of excess 
Zn(II) binds to a regulatory sequence that is located within the central znu operator region 
and prevents the binding and activity of RNA polymerase. This Zur dimer is only active in the 
reduced form [39]. The first binds Zn(II) very tightly and is functionally analogous to the 
Zn(II)-binding site in Fur, whereas Zn(II) is more readily exchanged in the second site in the 
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Zn(II) metallo-regulatory proteins SmtB from Synechococcus. Zur proteins seem to be 
widespread among gram-negative, gram-positive and cyanobacteria [36]. There is a group of 
porins in E. coli, which form a cylindrical, fluid-filled channels in the outer membrane of cells 
that allow selective hydrophilic solutes of up to 600 Da, including divalent metal cations such 
as Zn(II), to diffuse across into the periplasmic space. Zn(II) may then be imported into the 
cytosol of cells such as E. coli as neutral metal phosphate via the constitutively expressed 
inorganic phosphate uptake system (Pit) [40]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7 – Protein families involved in prokaryotic Zn(II) trafficking: ABC transporters, metallo-chaperones, porins 
and RND [41].  
 
Chaperones act to escort or usher interactive entities through the potentially hostile 
environments in which they find themselves. The primary function of the chaperones is to 
protect, preventing unfavourable interactions between the entity and the environment [36]. A 
family of soluble metal-binding proteins, known as metallo-chaperones are thought to 
facilitate the intracellular tracking of metal ions [42]. 
The export of the zinc can be made by different high and low-affinity exporters. One 
example of such exporters is the resistance-nodulation-cell division (RND) protein family, 
which exports excessive cations.  The RND protein family was first described as a related 
group of bacterial transport proteins involved in heavy metal resistance (R. metallidurans), 
nodulation (Mesorhizobium loti) and cell division (E. coli). The first member of this family to 
be identified was the CzcA protein from R. metallidurans [36]. This β-proteobacterium 
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contains two large plasmids involved in the heavy metal resistance. One of them, increased 
the MICs of Zn2+ by 50 fold [43]. 
Zinc-uptake can occur at the different levels of transporter synthesis and activity. One 
example is the zinc-binding protein-dependent transport systems, which were firstly 
identified in cyanobacteria and in pathogenic streptococci [44]. These bacterial metal 
transporters belong to the cluster 9 family of ABC transporters, which mainly transport zinc 
and manganese and which have been found in nearly all bacterial species. This high-affinity 
zinc-uptake system consists of the periplasmic binding protein ZnuA, the membrane 
permease ZnuB, and the ATPase ZnuC [45]. Most of the system of membrane transport 
mechanisms are controlled at the level of transcription and are mediated by metal-
responsive regulators, which modulate expression of genes in response to respective 
substrate concentrations. Hence, the cellular level of loosely bound, labile Zn(II) is sustained 
at close to required levels in conditions of either metal ion limitation or excess [36].  
 
2.5. NANOPARTICLES 
 
2.5.1. Properties 
 
Nanoparticles are generally defined as clusters of atoms in the size range of 1-100 
nm and they show distinct properties of their bulk equivalents. They usually contain 20-
15 000 atoms and can be produced from different materials in different shapes such as 
spheres, rods, wires and tubes (Fig. 8) [46].  
 
 
 
 
 
 
Some properties of nanoparticles remain unchanged from their bulk material 
equivalents. However, many other properties change as particle size decreases. A 
nanoparticle may have similar properties of their bulk equivalent and as well of their 
molecular precursors, due to its small size, therefore high surface area, and size-dependent 
properties (classical vs. quantum mechanics) [47].  
The chemical composition of the particles will affect their physicochemical properties 
and the core and the surface may be different. To determine nanoparticle composition, there 
are many techniques which can be used. Raman Spectroscopy, Inductively Coupled Plasma 
Fig. 8 – Possible shapes of nanoparticles: spheres, rods, wires and tubes. 
15 
 
- Optical Emission Spectrometry (ICP-OES), X-Ray Diffraction (XRD; for crystalline 
samples), and Fourier-Transform Infrared Spectroscopy (FTIR) are examples of such 
techniques [47]. 
Size is the key parameter for nanoparticles but it is not constant and is affected by 
the surrounding environment. For example, the size in the dry state may be very different 
from the one in a solvent, and different solvents impact size differently [48]. Although 
nanoparticles do not generally have a spherical shape, their size is usually defined as the 
diameter of a sphere [49]. 
The particle size distribution (PSD), i.e. the range of sizes of particles within a 
sample, gives an indication of the aggregation/agglomeration state of the nanoparticles [47]. 
There are several techniques which can be used to evaluate the PSD: Electron Microscopy 
(TEM and SEM), and Dynamic Light Scattering (DLS) are examples of such techniques. 
Electron Microscopy is more adequate for samples in the dry state because it is not 
influenced by solvent effects. DLS is a more adequate technique for solution studies, since it 
takes into account the environment [47]. Further details will be given in how to use DLS 
(Section 2.6.1).  
Nanoparticles present some limitations often related to their small size. Of particular 
importance is their instability over longer storage periods as they tend to agglomerate. This 
agglomeration reduces the high surface area to volume ratio, which may lead to the loss of 
their properties [50].  This formation of agglomerates is partly driven by van der Waals 
interactions. Agglomerations can also be formed due to increasing the particle concentration 
or changing the pH or ionic strength of the solvent [47]. This tendency for agglomeration can 
be explained by the difference in the thermodynamics of bulk materials and nanoparticles 
[51]. The free energy of the system (ΔG) is dependent on the material surface energy (ΔGs) 
and the free energy per unit volume (ΔGv): 
 
             
 
 
       
 
In nanoparticles, ΔGs is high and ΔGv is low, which makes the system free energy 
greater for a nanoparticle than for the bulk material of identical chemical composition. Thus, 
in order to reduce the system free energy, nanoparticles tend to agglomerate. Also, this 
higher system free energy affects many properties of the material, such as melting points 
and the crystallographic structure of nanoparticles [47]. This difference in thermodynamic 
properties is mainly due to the nanoparticle‟s high radius of curvature and high surface area 
and surface free energy [49].  
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2.5.2. Synthesis 
 
The synthesis of metallic nanoparticles can be divided into two alternative methods: 
the “bottom-up” approach and the “top-down” approach (Fig. 9). “Bottom-up”, can refer to 
self-assembly, i.e. the construction of a structure atom-by-atom, molecule-by-molecule, or 
cluster-by-cluster, in which the nanostructured building blocks are firstly formed and then 
assembled into the final material using chemical or biological procedure(s) for synthesis [52]. 
The formation of nanoparticles from atoms goes through two processes: (1) formation of 
primary particles and (2) agglomeration between the newly formed primary particles, which 
allow the formation of nanostructures [53]. This approach has an advantage of enhancing 
the possibility of obtaining metallic nanoparticles with comparatively lesser defects and more 
homogeneous chemical composition(s). In the “top-down” approach, the starting material is 
reduced in size using physical or chemical means. However, this approach has the 
disadvantage of producing structures with some imperfections in their surface, which can 
have a significant impact on physical properties and surface chemistry [52]. 
 
 
 
 
 
 
 
 
 
Fig. 9 – Diagram of how bottom-up and top-down approaches are processed [54]. 
 
The preparation of metal nanoparticles can also be categorized as a physical or a 
chemical approach. Physical strategies utilize methods such as inert gas condensation or 
laser ablation. With the inert gas condensation (IGC) method, a resistive source is used to 
evaporate the material at a low pressure of a non-reactive gas. Collisions among the 
material molecules lead to homogeneous nucleation and growth of nanoparticles, which can 
be collected onto a cold surface. Laser ablation is another physical method that involves the 
generation of nanoparticles by laser ablating a solid target that lies in a gaseous or a liquid 
environment and the nanoparticles are collected in the form of nanopowder or a colloidal 
solution [55]. One disadvantage of most of the physical processes is that the production rate 
of nanoparticles is quite low and also that these processes are highly expensive [56]. They 
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also lead to an enormous consumption of energy to maintain the high pressure and 
temperature used in the synthesis processes [52].  Chemical strategies rely on the metal 
ions in solution in conditions that allow the formation of small metal cluster or aggregates. 
The nanoparticles can be stabilized by using surfactants or ligands. 
The production of copper and zinc nanoparticles can use either chemical or physical 
methods. However, most synthesis strategies for copper nanoparticles production rely on 
chemical methods. The application of the nanoparticles has to be taken into account when 
choosing the method of synthesis. For instance, when producing nanoparticles for 
biomedical applications (e.g., antimicrobial), the end product has to be as less toxic as 
possible for human cells. 
 
2.5.3. Mechanisms of antimicrobial action 
 
One of the antimicrobial mechanisms of action of nanoparticles is the perforation of 
the cell wall. In fact, copper oxide (CuO; Cu(II)) nanoparticles  (1-10 nm) have shown 
antibacterial activity against E. coli and S. aureus and the interactions between nanoparticles 
and bacteria resulted in perforation of the cell wall. They also can show some selectivity, 
since that, in this case, the effect was more pronounced against the gram-negative 
organisms (E. coli). Also, the effect did not depend on the acquisition of resistance against 
antibiotics (studies were carried out on both antibiotic resistant and non-resistant strains of 
gram-negative bacteria). The higher effect on gram-negative bacteria may be due to the 
higher interaction between cell wall and nanoparticles by electrostatic forces [57].  
Zerovalent copper nanoparticles (Cu0) of 12 nm have been synthesized, using inert 
gas condensation, and their antibacterial activity was tested. The test was carried out 
against E. coli and it was observed that there was a reduction in CFUs (colony forming units) 
with increasing copper nanoparticle concentration in the growth medium. Also, as the 
surface of the bacteria was visualized by scanning electron microscopy, it was observed that 
after the interaction between bacteria and copper nanoparticles, the surface of the bacteria 
had some cavities and pits.  These results were attributed to the opposite charges of 
bacterial cell wall (negative) and copper ions released from nanoparticles (positive) leading 
to adhesion between them. More copper ions might have been allowed to enter the bacteria 
due to the fact that E. coli are gram-negative bacteria [58]. 
Copper nanoparticle antibacterial activity may also be due to penetration inside 
bacteria, where they are likely to produce damage by interacting with phosphorus and 
sulphur containing compounds, such as deoxyribonucleic acid (DNA), because they have 
high affinity with such compounds [58]. The antibacterial mechanism of copper nanoparticles 
has been attributed to the fact that Cu2+ ions leached from nanoparticles are absorbed by 
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bacteria when the nanoparticle concentration is high enough. Copper ions are absorbed 
onto the bacterial cell surface, damaging the cell membrane by solidifying protein structure 
or altering enzyme function [59]. Cu2+ ions entering cells combine strongly with intracellular 
amino acids and proteases, resulting in degeneration that leads ultimately to the 
denaturation of proteins [23]. Under physiological conditions, the intracellular enzyme activity 
of bacteria treated with copper nanoparticles is believed to increase, suggesting that 
permeability of the cell membrane also increased, resulting in bacterial injury. From these 
results, it is believed that the binding of copper ions to the bacterial cell surface plays an 
important role in the bactericidal activity [60]. 
The study of the effect of ZnO nanofluids against E. coli showed they have 
bacteriostatic activity against these bacteria. The antibacterial activity increased with 
increasing particle concentration and decreasing particle size.  Scanning electron 
microscopy (SEM) analysis of the bacteria before and after treatment with ZnO nanofluids 
showed that the presence of ZnO particles causes damages to the membrane wall of the 
bacteria. Such damage may be partly due to direct interaction between ZnO nanoparticles 
and the bacterial surface. Therefore ROS generated by ZnO particles could be part of the 
mechanism for damaging bacteria [61]. Another study of the toxicological impact of ZnO 
nanoparticles against E. coli has been carried out. E. coli cells were damaged and the cell 
contents may have leaked out. It was also observed that there was cellular internalization of 
these nanoparticles and cell wall disorganization [62].  
Although most of the time ZnO nanoparticles seem to be only bacteriostatic, a study 
of Campylobacter jejuni showed that ZnO has a bactericidal effect. The results showed that 
C. jejuni was extremely sensitive to treatment with ZnO nanoparticles of ~30 nm. It was 
possible to see that cell morphology, membrane integrity, and gene expression in these 
bacteria were affected by ZnO nanoparticles.  A dramatic change in the cell morphology was 
revealed, by showing the dominance of coccoid forms in the treated cells while the untreated 
remained spiral. In addition to this change in structure, ZnO nanoparticles resulted in the 
formation of irregular cell surfaces and “bubbles” in the membrane, an increase in 
membrane permeability, and a substantial increase in oxidative stress gene expression. This 
resulted in the inhibition of cell growth and eventually in cell death [63]. 
  
2.6. CHARACTERISATION TECHNIQUES 
 
2.6.1. Dynamic Light Scattering 
Dynamic light scattering (DLS) is a technique used to measuring the size of particles, 
typically in the sub-micron region. DLS is based on the scattering of light by moving 
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particles, i.e. it measures Brownian motion and relates it to the size of particles. Brownian 
motion is the random movement of particles due to the bombardment by the solvent 
molecules that surround them. The larger the particles, the slower the Brownian motion will 
be. Smaller particles are „kicked‟ further by the solvent molecules and move more rapidly . 
The velocity of the Brownian motion is defined by the translational diffusion 
coefficient (D) and that is what is measured in DLS. If the particles are spherical and do not 
interact, their radius can be calculated from the diffusion coefficient by the Stokes-Einstein 
equation:  
   
  
    
 
 
Where k is the Boltzmann‟s constant, T is the absolute temperature, η is the viscosity, and R 
the radius of the scatterers [65]. The translational diffusion coefficient will depend not only on 
the size of the particle “core”, but also on any surface structure, as well as the concentration 
and type of ions in the medium. The measurement of D is carried out by measuring the rate 
at which the intensity of the scattered light fluctuates when detected using a suitable optical 
arrangement. DLS works by having particles (for example in a cuvette), which are 
illuminated by a laser and then a screen is used to view the sample cell . The end result is 
then a size distribution by volume (Fig. 10). 
 
 
 
 
 
 
 
 
 
2.6.2. Zeta potential 
 
The zeta potential (ζ potential) is the electrostatic potential on the surface of a 
particle. Although particles may be electrically charged, the charge on the surface of each 
particle is counterbalanced by ions of opposite charge in the surrounding solution [66]. Thus, 
the liquid layer surrounding the particle has two regions; an inner region (Stern layer) where 
Fig. 10 – Size distribution graph obtained in for copper nanoparticles produced in the current project (n=3). In this 
case, the size distribution is reported in terms of volume percentage. 
20 
 
the ions are strongly bound and an outer (diffuse) region where they are less firmly 
associated. When the charges on the particle surface are attached the diffuse layer 
stretches out for some distance from the particle surface (Fig. 11). The surface that 
separates the bound charge from the diffuse charge around the particle marks where the 
solution and the particle move in opposite directions when an external field is applied. The 
electrostatic potential at this boundary (surface of hydrodynamic shear) is the zeta 
potential [66]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11 – Distribution of charge around a negatively charged particle [67]. 
 
  
The magnitude of the zeta potential gives an indication of the potential stability of the 
colloidal system. If all the particles in suspension have a large negative or positive zeta 
potential then they will tend to repel each other and there will be no tendency for the 
particles to agglomerate [66]. Thus, the knowledge of the zeta potential can be used to 
optimize the formulations of suspensions. 
A consequence of the existence of electrical charges on the surface of particles is 
that they interact with an applied field. When an electric field is applied across an electrolyte, 
charged particles are attracted towards the electrode of opposite charge. The particles move 
with constant velocity depending on the strength of the electric field or voltage gradient, the 
dielectric constant of the medium, the viscosity and the zeta potential. The velocity of a 
particle in a unit electric field is referred to as its electrophoretic mobility. Zeta potential is 
related to the electrophoretic mobility by the Henry equation: 
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Where UE = electrophoretic mobility, ζ = zeta potential, ε = dielectric constant, η = viscosity, 
and       = Henry‟s function . 
 
2.6.3. Inductively Coupled Plasma – Optical Emission Spectrometry 
 
Optical emission spectrometry (OES), also known as atomic emission spectrometry 
(AES), is a versatile, powerful, and sensitive method for elemental analysis. It involves 
nonradiative excitation of atoms or ions, followed by the emission of a photon that is 
collected by a detection system (Fig. 12). Although less sensitive than atomic spectrometry 
techniques coupled with mass spectrometers, OES is widely used because of its lower cost, 
reduced interferences, and sensitivity for many elements in the parts-per-billion range. The 
most commonly used atom cell for OES is the Inductively Coupled Plasma (ICP) [68]. ICP 
generates excited ions or atoms that emit electromagnetic radiation at wavelengths 
characteristic for certain elements. The concentration of the elements can be determined by 
the intensity of emission [69]. 
 
 
 
 
 
 
 
Inductively Coupled Plasma – Optical Emission Spectrometry is one of the several 
techniques available in analytical atomic spectroscopy. It utilizes plasma, which is an 
electrically neutral, highly ionized gas that consists of ions electrons, and atoms, as the 
atomization and excitation source. The energy that maintains the analytical plasma is 
derived from an electric or magnetic field, unlike in atomic absorption techniques there is no 
combustion, i.e. it is not a flame. Most analytical plasmas operate with pure argon or helium 
and are characterized by their temperature (assures that most samples are completely 
atomized), as well as their electron and ion densities. Analytical plasmas can range in 
temperature from 600 to 8000 K. ICP-OES is a total elemental technique, and one of its 
limitations is that it does not identify the oxidation state of the element [69]. 
Fig. 12 – Emission of radiation upon relaxation from an excited state. 
Excited 
Ground 
hv 
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2.6.4. X-ray diffraction 
 
X-ray diffraction (XRD) is an important technique for the identification, quantification, 
and characterisation of minerals.  It can provide information on phase composition, chemical 
composition, and the crystal structure of the material under analysis [70]. 
Solids can be divided into two categories: amorphous and crystalline. In an 
amorphous solid the atoms are arranged in a random way. In a crystal the atoms are 
arranged in a regular pattern, and there is a volume element that by repetition in three 
dimensions describes the crystal, i.e. a unit cell [71]. A macroscopic crystal then consists of 
a three dimensional, ordered arrangement of such unit cells and the geometry and structure 
of a crystalline solid determines the X-ray diffraction pattern. 
The unit cell has the dimensions a, b and, c along the axes x, y, and z. For 
determining absolute distances, the geometry of the unit cell, i.e. the lengths of the cell 
dimensions a, b, and c and the angles between the axes must be known [70].  
When an X-ray beam hits an atom, the electrons around the atoms start to oscillate 
with the same frequency as the incoming beam. In almost all directions there will be a 
destructive interference, i.e. the combining waves are out of phase and there is no resultant 
energy leaving the solid sample. However, the atoms in a crystal are arranged in a regular 
pattern, and in a very few directions there will be a constructive interference. The waves will 
be in phase an there will be well defined X-ray beams leaving the sample at various 
directions [72]. The interference pattern can be described by Bragg‟s law (Fig. 13): 
 
          
 
Where λ is the wavelength of the radiation, n is an integer number, θ is the angle between 
the lattice planes and the incident beam, and d is the distance of the lattice planes for which 
the peak occurs [70]. 
 
 
 
 
 
 
Fig. 13 – Geometric derivation of Bragg‟s law: constructive Interference of reflected waves [70]. 
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Amorphous materials have short-range order. Since the “quality” of diffraction effects 
in XRD depends strongly on the strict and undisturbed periodicity of atoms, any kind of 
deviation from the ideal order will show in the X-ray diagram. This results in the loss of 
distinct XRD peaks [70]. 
 
2.6.5. Antimicrobial activity assays 
 
For susceptibility tests to determine accurately the antimicrobial activity of a certain 
agent, standardization has to be achieved. The bacterial growth conditions must be 
optimized in a way that the inhibition of growth can be only linked to the presence of the 
antimicrobial agent and not to nutrient limitations, temperature or other environmental 
conditions [6].  
One possible method for the determination of antimicrobial activity is the disc-
diffusion assay. In this technique, discs containing known amounts of the antimicrobial agent 
are placed on a petri plate containing an agar medium previously inoculated with the test 
microorganism. The agent diffuses from the disc into the agar establishing a gradient. After 
incubation, the microorganisms will only grow beyond the point where the minimum inhibitory 
concentration (MIC), i.e. the lowest amount of agent that inhibits the growth of a test 
organism, is reached, but they do not grow closer to the disc where the amount of agent is 
higher. A zone of inhibition is created with a diameter proportional to the amount of 
antimicrobial agent added to the disc, the solubility of the agent, the diffusion coefficient, and 
the overall effectiveness of the agent [7]. The diameter of the zone of inhibition is then 
correlated to MICs obtained by broth or agar dilution [6]. The method presents several 
advantages, such as being easy to perform, cost effective, and easily adapted. However, 
this method is not suitable for tests with nanoparticles, since the diffusion of the 
nanoparticles is unknown. 
The antimicrobial activity of a certain agent can be measured by determining its MIC 
[7]. The MIC can be determined by dilution methods. In this type of tests the visible growth of 
microorganisms is tested on a series of agar plates (agar dilution) or in broth (broth dilution) 
containing dilutions of the antimicrobial agent [73].   
The agar dilution test consists in the in the inoculation of different agar plates 
containing various amounts of agent. After incubation, the plates are examined for growth 
and the MIC is the lowest concentration of the agent in agar that completely inhibits visible 
growth. This method has also been used for the determination of antibacterial activity of both 
copper and zinc nanoparticles [74, 75]. This is a highly sensitive method and is also easily 
adapted, but it also is labour intensive and very costly. 
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In broth dilution tests, the MIC is determined by making a sequence of decreasing 
concentrations of the agent in broth, which was inoculated with the test organism. Broth 
dilution tests can be divided into two categories: microdilution and macrodilution. The tests 
have the same basis and the only difference is the volume of broth in which the test is 
performed (0.05 to 0.1 mL and >1 mL, respectively). After incubation, the suspensions are 
tested for visible growth (turbidity) [7]. This method has been used for the determination of 
the antibacterial activity of both copper [57] and zinc [76] nanoparticles. The main 
advantages of this method are the generation of a quantitative result (MIC) and high 
throughput of results. However, the MIC value obtained is not accurate, since that this 
method only measures the total cell number and not the viable cells. When bacteria are 
killed, they remain in suspension and are accounted for the total cell number, which will have 
influence in the turbidity of the suspension. Thus, this method can be a good screening 
assay, but for more accurate results the method of agar dilution shall be carried out. 
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3. MATERIALS AND METHODS 
 
3.1. MATERIALS 
 
Copper (II) chloride dihydrate (CuCl2.2H2O; ≥ 99 %), D-glucuronic acid (C6H10O7; ≥ 
98 %), copper (II) acetate monohydrate (Cu(CO2CH3)2H2O;  ≥ 98 %), L-tartaric acid (Tart; 
99.5%), Adipic acid (Ad; 99%), L-cysteine (≥ 97 %), citric acid (≥ 99.5 %), sodium phosphate 
tribasic (Na3PO4; ≥ 94 %),  sodium dodecyl sulphate (SDS; 99%), 
octadecyltrimethylammonium bromide (CH3(CH2)17N(CH3)3Br), and zinc (II) chloride (ZnCl2;  
≥ 99 %) from Sigma were used. Sodium hydroxide (NaOH; 99.4%) from Calbiochem and 
DL-carnitine hydrochloride (C7H15NO3HCl; 99%) from Acros were also used. 
 
3.2. METHODS 
 
3.2.1. Synthesis 
 
3.2.1.1. Synthesis of ligand-modified copper hydroxide nanoparticles 
 
The basis of the method consisted in the preparation of a copper and ligands solution 
at low pH to which a base was added, such as sodium hydroxide (NaOH). Cu(OH)2, CuOH 
Glr, CuOH TartGlr, CuOH SDS, CuOH C18TAB, CuOH Car
1, were prepared using the salt 
copper chloride (CuCl2), whereas  CuOH TartAd synthesis used copper acetate 
(Cu(CO2CH3)2). All were prepared as described in patent WO/2008/096130.  
 
3.2.1.2. C18TAB modification of ligand-modified copper hydroxide 
nanoparticles 
 
Octadecyltrimethylammonium bromide (C18TAB) was added into a suspension 
containing CuOH SDS in order to prepare copper nanoparticles coated with C18TAB. The 
same procedure was used to prepare CuOH Tar nanoparticles coated with C18TAB. 
 
3.2.1.3. Heat treatment of ligand-modified copper hydroxide nanoparticles 
 
                                               
1
 This is an internal nomenclature, as the exact compositional formula was not determined. 
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Copper (II) chloride was added into sub-boiling water (90-100oC). The same 
procedure as the one described on patent WO/2008/096130 was followed and the sub-
boiling conditions were maintained. Tartaric acid was added as a ligand at different pHs. 
 
3.2.1.4. Synthesis of ligand-modified copper oxo-phosphates nanoparticles 
 
Cu3(PO4)2 and CuPO4 Cit were prepared using the salt copper (II) chloride (CuCl2) 
and Na3PO4 was used for the synthesis. The same procedure as the one described on 
patent WO/2008/096130. 
 
3.2.1.5. Synthesis of ligand-modified zinc oxide nanoparticles 
 
Zn(OH)2, and ZnOH Cys were prepared using the salt zinc (II) chloride (ZnCl2). All 
were prepared as described in patent WO/2008/096130. 
 
3.2.2. Characterisation of phase distribution 
 
Several samples were recovered at different pHs. A study on the phase distribution 
was carried out for all these samples. The soluble, nanoparticulate, and precipitate phases 
of copper in suspension were determined using inductively coupled plasma optical emission 
spectrometry (ICP-OES; JY 2000, Horiba). The samples were centrifuged (13 000 rpm, 5 
minutes) in order to remove the precipitate copper, i.e. agglomerated, thus enabling the 
measurement of the copper in the supernatant.  To obtain the soluble fraction, samples were 
ultra-filtered using a membrane of 3 KDa. Once the concentrations were obtained, the 
following calculations were done in order to obtain the copper or zinc phase distribution: 
 
                    
         
       
     
 
                        
                     
       
       
 
                                                                   
 
The same procedure was carried out for zinc suspensions. 
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3.2.3. ICP-OES 
 
Before determining the concentrations of total, supernatant, and soluble fractions by 
ICP-OES, each sample was diluted using 5% HNO3 for the complete dissolution of the 
copper or zinc, since that the analyte needs to be soluble for the analysis to take place. 
These dilutions were made in order to obtain concentrations within the calibration curve (Cu: 
0-100 ppm; Appendix 1). The samples were then analysed by ICP-OES (JY2000, Horiba 
Jobin Yvon), at a wavelength of 325 nm for copper and nm for zinc. 
 
3.2.4. Determination of particle size and zeta potential 
 
Both the particle size and zeta potential were determined by Dynamic Light 
Scattering (DLS; Zetasizer, Malvern Instruments) immediately after the particles had been 
synthesised. For the particle size distribution determination, the sample was placed into a 
low volume disposable sizing cuvette. The measurements were carried out for refractive 
index (RI) of 1.85, which is the refractive index for particles of this composition. For the zeta 
potential measurements a disposable zeta potential cell was used. The sample was placed 
carefully into this cell, avoiding the formation of bubbles. The same RI for the material as in 
the particle size measurements was used. The measurements for both particle sizing and 
zeta potential were carried out at a temperature of 25oC, using water as dispersant 
(viscosity=0.8872; RI=1.330; dielectric constant=78.5). It is important to define the medium 
in which the material is dispersed, because the composition of the disperse phase will have 
an impact on the particle size and zeta potential, as it is on the nature of the particle surface. 
The data analysis was carried out by using DTS software (Version 4.1; Malvern 
Instruments). 
 
3.2.5. XRD 
 
3.2.5.1. Sample preparation 
 
The suspensions were first oven dried at 50oC. The suspensions containing 
agglomerated particles were first centrifuged (3855 rpm, 20 min.) and the supernatant was 
discarded. After completely dry, the material was milled. 
  
3.2.5.2. Analysis 
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The analyses by XRD were carried out at the Earth and Environmental Department, 
University of Leeds. The unmodified and ligand-modified Cu(II) oxo-hydroxide, oxide and 
phosphate, and Zn(II) oxo-hydroxide materials were mixed with ethanol and pipetted onto a 
low background silicon holder. The diffraction data was collected with a Philips PW1050 
Powder Diffractometer using Cu K alpha radiation and a Ge secondary monochromator.  
The scanning range was 5-70 deg 2 theta at a speed of 0.8 deg/min and a step size of 0.01 
deg. TRACES software with the ICDD (international centre for diffraction data) database was 
used to process the data. 
 
3.2.6. Antibacterial activity tests 
 
The nanoparticle suspensions were tested against Escherichia coli NCTC11100. 
Bacteria were grown overnight at 37oC in sterile broth (Iso-sensitest broth, Oxoid). The tests 
were carried out in a 96-well plate, with different amounts of bacteria (decimal dilutions of an 
initial culture; 10-1, 10-2, 10-3, 10-4, and 10-5) and different concentrations of copper- or zinc-
based particles (25, 50, and 100 ppm of either copper or zinc). A turbidimetric assay was 
used to determine the inhibition of bacterial growth. This method relies on the scattering of 
light caused by the bacterial cell surface, which presents a high refractive index. The 
reduction of transmitted light can be then measured by optical density and related to relative 
bacterial growth. The bacterial growth was carried out at 37oC and the measurements were 
taken at 595 nm with a plate reader (Multiskan RC 351, Labsystems), at 0, 2, 4, and 6 hours. 
The inhibition percentage for the bacterial growth presented throughout this 
dissertation corresponds to the one at 100 ppm of copper or zinc, 10-2 bacterial dilution, and 
6 hours. The inhibition at 100 ppm was chosen because this is the best inhibition, due to the 
higher concentration. The 10-2 amount of bacteria is also the best one because with this 
amount the growth does not reach a plateau (for the 10-1 it does). The time chosen was 6h 
due to the linear growth observed at that time, which does not happen before. Refer to 
Appendix 2 for the standard growth curves. 
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4. RESULTS AND DISCUSSION 
 
4.1. COPPER 
 
Copper, when in solution (i.e. in ionic form), acts as a Lewis acid, being an electron 
pair acceptor. Thus, when copper (II) chloride (CuCl2) is dissolved in water the resulting 
solution has a low pH:  
 
                 
                         (2) 
        
                      
      
  (3) 
             
As a control experiment for the production of unmodified copper oxo-hydroxides, the 
pH of a solution of copper (40 mM) was adjusted drop-wise with NaOH. Initially, copper 
remained soluble at very acidic pH‟s, but as the pH was raised (>pH4), copper started to 
precipitate (Fig. 14). This precipitation is due to the formation of unmodified copper oxo-
hydroxide particles, which are insoluble, and, for example, Cu(OH)2 is formed according 
equation 3: 
 
                             (4) 
 
 
                                        
 
 
 
 
 
 
 
 
 
 
 
A mineral phase is a mineral system with homogenous physical and chemical 
properties, i.e. a system where the composition and tridimensional arrangement are uniform. 
Fig. 14 – Copper phase distribution (%) with varying pH during the synthesis of copper oxo-hydroxide 
([Cu]=40 mM). 
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The mineral phase of the obtained particles was paratacamite (Cu2Cl(OH)3; trigonal-
rhombohedral), as determined by XRD in the previous work [77]. The agglomeration of the 
copper oxo-hydroxide particles has to be controlled in order to produce smaller particles, i.e. 
to produce nanoparticles. 
 
4.1.1. Ligand effect 
 
Previous work at MRC-HNR [77], showed it is possible to obtain modified copper 
oxo-hydroxide nanoparticles with sizes between 3-5 nm, using tartaric acid  and adipic acid 
as ligands (Fig. 15). Tartaric acid is a natural occurring dicarboxylic acid with two proton 
donor centers, two carboxylic and two hydroxyl groups (pKa=3.03; pKa=4.37 [78]). Adipic 
acid is also a dicarboxylic acid with the same proton donor centres (pKa=4.44; pKa=5.44 
[78]). These two ligands act as dispersive agents, avoiding the excessive agglomeration of 
the particles and thus allowing the control of the particle size. However, these nanoparticles 
were labile and dissolved partially in bacterial broth (medium used in the antimicrobial 
assay). Thus, the current work is focused on the development of copper nanoparticles with 
different ligand combinations to make them more stable. As for the previous work [77] safety 
was a key determinant in the choice of ligands. To ensure this, almost all ligands tested were 
dietary ligands, i.e. typically present in a normal diet. Low cost was an additional advantage 
of using dietary ligands, which would, in principle, lead to low manufacturing costs. 
Furthermore, all ligands were GRAS (Generally Recognized as Safe) as it further ensured a 
good safety profile for the resulting materials. 
 
 
 
 
 
 
 
Glucuronic acid is a carboxylic acid, with a structure similar to glucose (Fig. 16) and 
has a pKa of 3.18 [78]. The interaction with copper should also be via the carboxylic group 
and the several –OH groups would lead to a higher stabilization [79]. Thus, this ligand was 
tested to attempt a higher stabilization of the nanoparticles. The concentrations used in this 
case were 40 mM of copper (II) and 40 mM of glucuronic acid and the same method was 
followed. The copper phase distribution was studied (Fig. 17). At pH 2, before NaOH had 
been added, all copper was soluble. However, approximately at pH 5, there was a 
Fig. 15 – Structures of tartaric acid (A) and adipic acid (B). 
A B 
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substantial precipitation. The yield on the production of nanoparticles was very low and it 
was concluded that this ligand alone is ineffective in the production of nanoparticles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The use of glucuronic acid as a ligand did not lead to the formation of copper oxo-
hydroxide nanoparticles. To further disperse these particles, tartaric acid (20 mM) was used 
along with glucuronic acid (20 mM), using a 40 mM solution of copper (II). The copper phase 
distribution obtained during this synthesis (Fig. 18) shows that a great amount of 
nanoparticles were formed (95.5%, pH 9.2). The particle size varied according to pH. At pH 
6 (Fig. 19A) the mean size of the particles was 1.4 nm and at pH 10 it was 2.6 (Fig. 19B). 
Next, the effect of dilution in broth on the copper phase distribution was studied (Fig. 20). 
There was a partial dissolution of the nanoparticles at all concentrations. In fact, only ~50% 
of the copper remained nanoparticulate. This shows that the obtained nanoparticles were not 
stable. Nevertheless, these nanoparticles were tested against E. coli (Fig. 21). Although the 
nanoparticles produced a greater inhibition (57.8%) than a copper (II) chloride solution 
Fig. 16 – Structure of glucuronic acid 
Fig. 17 - Copper phase distribution (%) with varying pH during the synthesis of copper (II) oxo-hydroxide 
([Cu]=40 mM) in the presence of glucuronic acid (40 mM). 
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(41.0%), the bactericidal action was still below intended. These results may be due to the 
partial dissolution of the nanoparticles when in broth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A – pH 6  
B – pH 10  
Fig. 19 - Particle size distribution at various pH‟s during the synthesis of copper oxo-hydroxide ([Cu]=20 mM) in 
the presence of tartaric acid (20 mM) and glucuronic acid. (A) pH 6; (B) pH 10. 
Fig. 18 - Copper phase distribution (%) with varying pH during the synthesis of copper (II) oxo-hydroxide 
([Cu]=40 mM) in the presence of tartaric acid (20 mM) and glucuronic acid (20 mM). 
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4.1.1.1. Other ligands 
 
Other ligands were tested for the production of copper oxo-hydroxide nanoparticles, 
such as cysteine, histidine, phenylalanine, tryptophan, alanine, and maltol. None of this 
ligands resulted in the production of a high yield of nanoparticles. However, the use of these 
ligands allowed a better understanding on how the production of copper oxo-hydroxide 
nanoparticles works. For example, the use of ligands with a high affinity to copper, such as 
cysteine and histidine, did not result in the production of copper oxo-hydroxide nanoparticles. 
They may work on the production of nanoparticles of a different mineral phase, but they do 
not seem to work for paratacamite related phases. For the sake of conciseness, these 
experimental data has not been reported in this Thesis. 
 
4.1.2. Increasing stability 
 
4.1.2.1. Copper salt 
 
Copper chloride was replaced by copper acetate to test the effect of using a different 
copper salt. This should lead to the production of a different mineral phase other than 
paratacamite (Cu2Cl(OH)3) due to the replacement of chloride ions by acetate. When copper 
oxo-hydroxide is produced using copper acetate, the copper phase distribution at increasing 
pH varies according to Fig. 22. The precipitation occurs at a pH between 5 and 6. 
Fig. 20 - Copper phase distribution (%) of CuOH 
TartGlr diluted in broth at concentrations 1, 10 and 
100 ppm. 
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Fig. 21 – Inhibition of growth of E. coli by CuOH 
TartGlr nanoparticles at 6h, 100 ppm of copper, and 
10
-2 
bacterial dilution. The white column represents 
the results for control (40 mM solution of copper 
chloride) and the grey one for the suspension.  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
In
h
ib
it
io
n
 o
f 
gr
o
w
th
 (
%
) 
Control
CuOH TartGlr
34 
 
Nanoparticles were produced at pH 6.2 but as the pH increased these nanoparticles 
agglomerated and at pH 7 most of the copper was precipitated. These particles were also 
characterized by XRD (Fig. 23), showing that there was a significant agreement with the 
XRD pattern for copper (II) hydroxide (Cu(OH)2). This informed that due to the absence of 
chloride in this experiment, the mineral phase paratacamite (Cu2Cl(OH)3) was not obtained. 
Instead, Cu(OH)2 was obtained, however, some of the peaks could not be identified. They 
may correspond to other mineral phases formed during the synthesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22 - Copper phase distribution (%) with varying pH during the synthesis of copper oxo-hydroxide 
([Cu]=40 mM) using a different copper salt. 
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Fig. 23 – XRD characterization of copper oxo-hydroxide particles using a different copper salt. The lines in red 
represent the XRD reference for copper (II) hydroxide (Cu(OH)2). 
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Next, to produce modified copper (II) hydroxide nanoparticles, tartaric acid and adipic 
acid (20 mM each), which were previously shown to be good dispersive agents for the 
production of copper oxo-hydroxide nanoparticles, were added to a solution containing 40 
mM of copper acetate. Here, the highest amount of nanoparticles (77%) was obtained at 
pH 8 (Fig. 24). In this synthesis the level of precipitation remained constant throughout the 
synthesis (~15%).  The analysis of the particle size distribution at pH 7 showed that the 
nanoparticles had an approximate mean size of 2 nm (Fig. 25A) but at pH 8 they were 
larger, they had an approximate mean size of 4.5 nm (Fig. 25B). The mean size of the 
nanoparticles increased with pH, which may have made them more stable. The 
characterization of these particles by XRD showed that a significant fraction of sodium 
acetate hydrate was obtained in this synthesis (C2H3NaO2·3H2O), since some of the peaks 
match the XRD reference for this mineral phase (Fig. 26). Again it was not possible to 
identify a pattern for a copper mineral phase, which may mean that an amorphous material 
was produced, due to the integration of the ligands in the particle structure. It was also not 
possible to identify some of the peaks. The antibacterial activity of this material against E. 
coli was tested (Fig. 27), presented more than 50% of inhibition in relation to copper free 
media, but, when compared to the control (copper (II) acetate solution) at the same 
concentration, the results were equivalent, which indicates that the nanoparticles did not 
have a greater effect than copper in solution. This may have been due to the solubilisation of 
the nanoparticles when in broth, meaning that the problem of the instability of the 
nanoparticles was not overcome by using a different source of copper. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24 - Copper phase distribution (%) with varying pH during the synthesis of copper oxo-hydroxide ([Cu]=40 
mM) using a different copper salt and in the presence of tartaric acid (20 mM) and adipic acid (20 mM). 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
3 4 5 6 7 8 9
C
o
p
p
e
r 
p
h
as
e
 d
is
tr
ib
u
ti
o
n
 (
%
) 
pH 
Soluble %
Nano %
Precip. %
36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25 - Particle size distribution at various pH‟s during the synthesis of copper oxo-hydroxide ([Cu]=40 mM) in 
the presence of tartaric acid (20 mM) and adipic acid (20mM) (A) 7.0; (B) pH 8.0. 
A – pH 7.0 
B – pH 8.0  
      Sodium acetate hydrate - 
(C2H3NaO2·3H2O) 
Fig. 26 – XRD characterization of copper oxide nanoparticles. The lines in blue represent the XRD reference for 
Sodium acetate hydrate (C2H3NaO2·3H2O). 
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4.1.2.2. Copper oxides 
 
Modified copper oxide (CuO) nanoparticles have been reported to show antibacterial 
activity [80]. CuO nanoparticles have also shown great cytotoxicity for eukaryotic cells which 
has been hypothesized to be due to a „Trojan-horse‟ effect, i.e. once they reach the 
lysosomes, they solubilize due to the lower pH inside them, leading to the release of copper 
ions inside the cell [81]. However, the aim of this project is to produce nanoparticles that 
interact with the cell membrane rather than penetrating it.  Oxide based nanoparticles may 
be more stable, due to the nature of the mineral phase. So CuO nanoparticles were 
produced at high temperatures and this mineral phase was identified during the synthesis by 
the observation of the suspension colour, which should be black rather than blue [82].  
As a control experiment for the production of copper oxides, a 40 mM copper (II) 
solution was added to water at sub-boiling temperature and then the pH was gradually 
increased. Before adding NaOH, 60% of the copper was soluble (Fig. 28). There were also a 
nanoparticulate fraction (30%) and some precipitate (10%). As NaOH was added, there was 
a substantial precipitation and all the copper was precipitated. This precipitate was then 
characterized by XRD (Fig. 29), which showed that the mineral phase of the obtained 
particles is tenorite, a phase chemically constituted of nearly pure copper (II) oxide (CuO) 
[83]. Halite (NaCl) was also found but this was expected, since the copper salt used was 
copper (II) chloride and the base was NaOH. 
Fig. 27 – Inhibition of growth of E. coli by 
CuOH Tart Ad nanoparticles synthesised using a 
different copper salt (copper (II) acetate) at 6h, 100 
ppm of copper, and 10
-2 
bacterial dilution. The white 
column represents the results for control (40 mM 
solution of copper (II) acetate) and the grey one for 
the suspension.  
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For the production of copper oxide nanoparticles, tartaric acid was used as a ligand, 
since it has been shown to be a good dispersive agent for copper. A solution of copper (II) 
was added to sub-boiling water with a final concentration of 40 mM. Then, a solution 
containing tartaric acid was also added (final concentration=40mM) and NaOH was added 
drop-wise. The copper phase distribution was studied (Fig. 30) and also the progression of 
Fig. 28 - Copper phase distribution (%) with varying pH during the synthesis of copper oxide ([Cu]=40 mM) 
under heating. 
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Fig. 29 – XRD characterization of copper oxide particles. The lines in red represent the XRD reference for 
Tenorite (CuO) and the blue ones for Halite (NaCl). 
      Tenorite - CuO 
      Halite - NaCl 
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colour was observed as it can be informative of mineral phases. At low pH most of the 
copper was soluble. When the pH was raised to pH 2.4, there was some precipitation and 
the amount of soluble and precipitate copper was roughly the same. By this time, the colour 
of the suspension was light blue. However, as the pH was raised, nanoparticles started to 
form and the suspension turned into a clear dark blue. The highest amount of nanoparticles 
was obtained at pH 10.0 and at this pH the suspension turned into dark green which may be 
due to a mixture of copper oxo-hydroxide and CuO particles. Then at pH 12.4 a substantial 
precipitation occurred and the colour turned into dark brown, possibly due to a further 
mineral phase change. Overall, CuO particles appear to have been formed, but they were 
not nano-sized. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The previous synthesis resulted in the production of large copper oxide particles and, 
to tackle this effect, the concentration of tartaric acid was increased to 80 mM. With this 
increase on the concentration of tartaric acid, its dispersive power should be higher and thus 
nanoparticles could be produced. Before adding any NaOH, at pH 1.7, most copper was 
soluble but when the pH was raised to 2.8, there was a substantial precipitation (Fig. 31), 
similarly to what happened in the previous experiment. At pH 4.8, nanoparticles were 
present and their amount kept rising for higher pHs. The suspension turned into clear dark 
blue and remained with this colour till the end of the titration. Thus, such a high 
concentration of tartaric acid did not allow the production of CuO nanoparticles and only 
copper oxo-hydroxide nanoparticles were produced.  
 
Fig. 30 – Copper phase distribution (%) with varying pH during the synthesis of copper oxide ([Cu]=40 mM) in the 
presence of tartaric acid (40 mM) under heating. 
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To test the effect of adding tartaric acid after CuO particles appeared to be already 
formed without any ligand, a 40 mM copper (II) solution was added to water at sub-boiling 
temperature and at high pH. After adding tartaric acid to this suspension (final 
concentration=20 mM), the copper remained precipitate (Fig. 32). The characterization of 
these particles by XRD shows that tenorite (CuO) was also produced, since most of the 
peaks obtained match with those of the pattern of this mineral phase (Fig. 33). This means 
that even in the presence of tartaric acid, CuO is formed and that the ligand is not integrated 
in the particle structure.  
 
 
 
   
 
 
 
 
 
 
 
 
 
Fig. 31 – Copper phase distribution (%) with varying pH during the synthesis of copper oxide ([Cu]=40 mM) in the 
presence of tartaric acid (80 mM) under heating. 
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Fig. 32 – Copper phase distribution (%) 
during the synthesis of copper oxide 
nanoparticles ([Cu]=40 mM) in the 
presence of tartaric acid (20 mM) under 
heating. 
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Cysteine (Fig. 34) is a neutral amino acid (pKa=1.92 – COOH; pKa=8.37 – SH; 
pKa=10.70 –NH3
+ [78]) and is one of the two sulphur-containing amino acids. This amino 
acid has a high affinity for copper and forms complexes with this metal through the thiol 
group [84]. Due to its structure features, it can also lead to the production of nanoparticles. 
This ligand was also added to a suspension of CuO particles. Nanoparticles were obtained 
and the yield was 86.6% (Fig. 35). When this suspension was diluted in broth, a higher 
percentage of the copper remained nanoparticulate when comparing to the previous 
suspensions (Fig. 36). These nanoparticles are more stable than the ones previously 
synthesised but there is still a great dissolution of the nanoparticles. This suspension was 
also tested against E. coli. The results revealed to be worse than the copper (II) chloride 
solution and any other previous results, since an inhibition of only 16.3% was obtained (Fig. 
37). Although these nanoparticles were more stable than the previous ones, they did not 
show relevant antimicrobial activity. 
 
 
 
 
Fig. 33 – XRD characterization of copper oxide particles modified with tartaric acid. The lines in red represent 
the XRD reference for Tenorite (CuO) and the blue ones for Halite (NaCl). 
      Tenorite - CuO 
      Halite - NaCl 
Fig. 34 – Structure of cysteine. 
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4.1.2.3. Copper phosphates 
 
Another possible way to obtain nanoparticles of a different mineral phase is by 
substituting the –OH groups for other groups such as     
  . By increasing the pH of a 
solution containing 40 mM with Na3PO4, the copper precipitates at around pH 4 (Fig. 38). 
The copper remains agglomerated till pH 10. The characterization of these particles by XRD 
shows that a great part of the peaks obtained matches with the XRD pattern of a mixture of 
Fig. 35 - Copper phase distribution (%) 
during the synthesis of copper oxide 
nanoparticles ([Cu]=40 mM) in the 
presence of cysteine (40 mM) under 
heating. 
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Fig. 37 – Inhibition of growth of E. coli by CuO Cys 
nanoparticles at 6h, 100 ppm of copper, and 10
-2 
bacterial dilution. The white column represents the 
results for control (40 mM solution of copper (II) 
chloride) and the grey one for the suspension. 
Fig. 36 - Copper phase distribution (%) of CuO Cys 
diluted in broth at concentrations 1, 9 and 84 ppm. 
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two copper hydrogen phosphate hydrate mineral phases:  Cu4H(PO4)3·3H2O and 
CuHPO4·H2O (Fig. 39). Thus, the use of Na3PO4 resulted in the production of unmodified 
copper phosphates of two different compositions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Citric acid is a symmetric tricarboxylic acid (Fig. 40) and is naturally occurring 
(pKa=3.13; pKa=4.76; pKa=6.40 [78]). This weak organic acid has been previously used for 
the production of copper oxo-hydroxide nanoparticles [77]. Thus, it was used for the 
Fig. 38 – Copper phase distribution (%) with varying pH during the synthesis of copper phosphate 
([Cu]=40 mM). 
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Fig. 39 – XRD characterization of unmodified copper phosphate particles. The lines in blue represent the XRD 
reference for Cu4H(PO4)3·3H2O and the green ones for CuHPO4·H2O. 
      Copper hydrogen phosphate hydrate - Cu4H(PO4)3·3H2O 
      Copper hydrogen phosphate hydrate - CuHPO4·H2O 
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production of copper phosphate nanoparticles. As the pH was increased nanoparticles 
started to form (Fig. 41). The highest amount of nanoparticles (63.6%) was obtained for pH 
9.28. At pH 6.1, the mean particle size was 1.0 nm (Fig. 42). The characterization of these 
nanoparticles by XRD is shown on Fig. 43. The only identified peaks corresponded to halite 
(NaCl). The XRD pattern was compared with the XRD references of several copper 
phosphate phases (cornetite - Cu3(PO4)(OH)3; libethenite - Cu2(PO4)(OH); ludjibaite - 
Cu5(PO4)2(OH)4; pseudomalachite - Cu5(PO4)2(OH)4; reichenbachite - Cu5(PO4)2(OH)4), but 
the peaks could not be identified. These unidentified peaks are broad, which may indicate 
that we are in the presence of an amorphous phase, possibly due to the integration of the 
ligand in the particle structure. Although the yield on the production of nanoparticles was not 
high, the copper phase distribution of these nanoparticles at pH 6 when diluted in broth was 
still tested (Fig. 43).  Only a small portion of nanoparticles dissolved because to start with 
there was only 57% of nanoparticulate copper. The results of the antimicrobial activity test 
show that a higher inhibition of the bacterial growth was also obtained (Fig. 44). Although, a 
better result was obtained, these nanoparticles also did not show a complete efficacy on the 
inhibition of bacterial growth (Fig. 45). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 41 – Copper phase distribution (%) with varying pH during the synthesis of copper phosphate nanoparticles 
([Cu]=40 mM) in the presence of citric acid (40mM). 
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Fig. 40 – Structure of citric acid. 
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Fig. 42 - Particle size distribution at pH 6 during the synthesis of copper phosphates ([Cu]=40 mM) in the 
presence of citric acid (20 mM). 
Fig. 43 – XRD characterization of CuPO4 Cit nanoparticles. The lines in red represent the XRD reference for 
Halite (NaCl). 
      Halite - NaCl 
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4.1.3. Lamellar structures 
 
Another way of producing and stabilizing nanoparticles is by using surfactant 
structures, namely lamellar structures. In fact, surfactants may act as stabilizers, capping 
agents, and/or a template, thus controlling size, growth and/or agglomeration of 
nanoparticles [85]. There are different types of surfactants, and they can vary in charge. An 
example of an anionic surfactant is sodium dodecyl sulphate (SDS) and an example of a 
cationic one is octadecyltrimethylammonium bromide (C18TAB).   
 
4.1.3.1. Negatively charged 
 
SDS (Fig. 46) has also been used as a dispersive agent for the production of metal-
based nanoparticles [86, 87]. It can act as a dispersive agent due to its hydrophobic chain, 
preventing the particles from agglomerating. Thus, 20 mM of copper (II) and 10 mM of SDS 
(a concentration slightly above its critical micelle concentration, which is 7-8 mM in water 
[55]) was used in the synthesis. The copper phase distribution during the synthesis can be 
seen on Fig. 47. With this method, nanoparticles were not formed and a substantial 
precipitation occurred at pH 5. The particle size distribution was determined by dynamic light 
scattering, confirmed that the particles were not in true nano range (pH 6.9; Fig. 48), i.e. 
were larger than 100 nm.  
 
 
Fig. 46 – Structure of sodium dodecyl sulphate (SDS). 
Fig. 44 - Copper phase distribution (%) of CuPO4 Cit 
diluted in broth at concentrations 1, 10 and 103 ppm. 
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Fig. 45 – Inhibition of growth of E. coli by CuPO4 Cit 
nanoparticles at 6h, 100 ppm of copper, and 10
-2 
bacterial dilution. The white column represents the 
results for control (40 mM solution of copper (II) 
chloride) and the grey one for the suspension. 
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The pH at which SDS is added may have an effect on the production of nanoparticles 
and, to test this parameter, this surfactant was added at pH 6.5 after the copper oxo-
hydroxide particles had already been produced. When SDS was added, the pH changed 
from 6.5 to 6.9, but other than that, the results were almost the same as for the previous 
experiment: even after adding SDS, the particles were large (Fig. 49). Also, it is possible to 
see that on the previous experiment the ligand did not have influence on the precipitation of 
the copper, since the precipitation occurred at about the same pH. By observing the particle 
size before adding SDS, it is possible to see that there were two populations of particles, 
both of them with sizes higher than 100 nm (Fig. 50A). After adding SDS, the particle size 
was still higher than 100 nm, but apparently some of the particles diminished in size (Fig. 
50B). At a higher pH (7.7) the results were the same, which means that the increasing in the 
pH did not have a great effect on the particle size (Fig. 50C). Thus, the addition of SDS at a 
higher pH, after copper oxo-hydroxide particles were formed, did not lead to the production 
Fig. 48 - Particle size distribution at pH 6.9 during the synthesis of copper oxo-hydroxide ([Cu]=20 mM) in the 
presence of SDS (10 mM). 
Fig. 47 - Copper phase distribution (%) with varying pH during the synthesis of copper oxo-hydroxide 
([Cu]=20 mM) in the presence of SDS (10 mM). 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
3 4 5 6 7 8
C
o
p
p
e
r 
p
h
as
e
 d
is
tr
ib
u
ti
o
n
 (
%
) 
pH 
Soluble %
Nano %
Precip. %
48 
 
of nanoparticles. In this case SDS did not act as a dipersant, probably due to the formation 
of large micelles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 50 - Particle size distribution at various pH‟s during the synthesis of copper oxo-hydroxide ([Cu]=20 mM) to 
which SDS (10 mM) was added at pH 6.5. (A) pH 6.5 (-SDS); (B) pH 6.9 (+SDS); (C) pH 7.7 (+SDS). 
A – pH 6.5  
B – pH 6.9 
  
C – pH 7.7 
  
Fig. 49 - Copper phase distribution (%) with varying pH during the synthesis of copper oxo-hydroxide ([Cu]=20 
mM) to which SDS (10 mM) was added at pH 6.5. 
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4.1.3.2. Positively charged 
 
Octadecyltrimethylammonium bromide (C18TAB; Fig. 51) was also tested to produce 
copper nanoparticles.  It is a cationic surfactant and it was added to the suspension 
previously prepared (Cu + SDS, pH 7.7) with a final concentration of 10 mM. This surfactant 
was added in order to act as a dispersive agent and coat the particles, making them 
positively charged rather than negatively, which may result in a higher interaction between 
the nanoparticles and the bacterial membrane. However, particle size remained over 100 nm 
(Fig. 52), which means that the addition of this ligand did not have a pronounced effect on 
particle size and that the two surfactants together did not dispersed the particles, possibly 
due to charge neutralization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To determine if oxo-hydroxide particles could be produced using tartaric acid as a 
ligand as previously were further dispersed by the addition of C18TAB, another experiment 
was carried out. NaOH was added to a 20 mM copper (II) and 10 mM tartaric acid solution 
and, at pH 6.4, C18TAB was added (10 mM). Before adding C18TAB there were polydisperse 
population of particles, some of them with sizes below 100 nm (Fig. 53A). However, with the 
addition of C18TAB, all particles had sizes over 100 nm (Fig. 53B). It seems that C18TAB 
induced the nanoparticles that were present to agglomerate, instead of acting as a 
dispersive agent. 
 
Fig. 52 - Particle size distribution at pH 7.4 during the synthesis of copper oxo-hydroxide ([Cu]=20 mM) to which 
SDS (10 mM) was added at pH 6.5 and C18TAB (10 mM) was added at pH 7. 
Fig. 51 - Octadecyl trimethyl ammonium bromide (C18TAB). 
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4.1.4. Positively charged nanoparticles 
 
The surface charge of the nanoparticles may have an influence on their interaction 
with the bacterial membranes. The bacterial membranes present a net negative electrostatic 
surface charge [88] and positively charged nanoparticles may have a greater interaction with 
bacteria. So far, the nanoparticles obtained should have a negatively charged surface. The 
zeta potential can be measured for particles with a very high refractive index (e.g. gold) 
down to 2 nm. The oxo-hydroxides of transition metals are not as refractive and, typically, 
the measurements can only be performed for particles with 10-15 nm or greater. Thus, it was 
not possible to measure the potential of the nanoparticles previously prepared, since they 
were too small. However, it was possible to measure the zeta potential for CuOH TartAd. 
The  method for the production of the nanoparticles was the same as the one used in 
previous work [77]. Note that these particles were recovered at pH 6, since that at this pH 
the particles are partly agglomerated thus enabling the zeta potential measurement. The 
mean zeta potential obtained was -14.6 mV (Fig. 54), which confirms that this type of 
nanoparticles are negatively charged. This may have led to a lower interaction between 
nanoparticles and bacterium cell wall. The zeta potential indicates also the level of stability of 
Fig. 53 - Particle size distribution at various pH‟s during the synthesis of copper oxo-hydroxide ([Cu]=20 mM) in 
the presence of tartaric acid (10 mM), to which C18TAB (10 mM) was added at pH 6.4. (A) pH 6.4 (-C18TAB); (B) 
pH 7.4 (+C18TAB). 
A – pH 6.5  
B – pH 7.4  
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the nanoparticles and, in this case, it indicates that the nanoparticles are quiet unstable, 
since that the higher the zeta potential, the more stable are the particles.   
 
 
 
 
 
 
 
 
 
 
 
 In order to obtain positively charged nanoparticles, carnitine (Fig. 55) was used as a 
ligand. At physiological pH, carnitine is a zwitterion (pka=3.80 [78]), i.e. the molecule is 
neutral, but it presents a positive and a negative charge at different sites. The expected 
interaction between carnitine and copper should be via the carboxylic group (negatively 
charged), while the amine group should be oriented to the outside of the particles, giving a 
positive charge to the surface of the particle. Since carnitine shares some functional groups 
with tartaric acid, it may also act as a dispersive agent, allowing the production of 
nanoparticles. Thus, the effect of this ligand on the production of copper oxo-hydroxide 
nanoparticles was tested. A solution containing 20 mM of copper (II) and 20 mM of carnitine 
was prepared and its pH was increased by adding NaOH. The copper phase distribution as 
the pH was increased (Fig. 56) shows that from pH 6.5 there was a substantial precipitation. 
According to these data, nanoparticles were not formed during this synthesis. The particle 
size distribution was determined and for pH 6.5 the particles had a mean size of 124 nm 
(Fig. 57). The obtained particles are not in the so called nano-range but they are submicron. 
The zeta potential of these nanoparticles was also determined. At pH 6.5 the particles had a 
mean zeta potential of 39.1 mV (Fig. 58) which indicates that the surface of the 
nanoparticles is positively charged. These particles were also characterized by XRD 
(Fig. 59). The mineral phase obtained in this case was the same as the one obtained for 
unmodified copper oxo-hydroxides, paratacamite (Cu2Cl(OH)3). This may indicate that the 
carnitine does not make part of the structure of the particles, but it is coating them. A study 
on the copper phase distribution when these particles were diluted in broth shows that a part 
of the submicron particles decrease size, they became nanoparticulate, and that a part of 
these particles solubilised (Fig. 60). Thus, the problem with instability of the particles 
Fig. 54 – Zeta potential distribution at pH 6 of CuOH TartAd, using water as dispersant. 
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obtained so far was not overcome by using this ligand. Also, even though the particles were 
larger, a partial solubilisation occurred. Nevertheless, their antimicrobial activity was tested. 
The results show that the particles led to a 68% inhibition of the bacterial growth (Fig. 61) 
and, although quite a substantial improvement in relation to the previous one was achieved, 
the bactericidal effect is still insufficient. The positive charge of the particles may have led to 
a higher interaction with the bacterial membrane but the antimicrobial activity was not much 
higher than the ones before. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 57 - Particle size distribution at pH 6.5 during the synthesis of copper oxo-hydroxide ([Cu]=20 mM) in the 
presence of carnitine (20 mM). 
Fig. 56 - Copper phase distribution (%) with varying pH during the synthesis of copper oxo-hydroxide ([Cu]=20 
mM) in the presence of carnitine (20 mM). 
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Fig. 55 – Structure of carnitine. 
53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 59 – XRD characterization of copper (II) oxo-hydroxide particles modified with carnitine. The lines in red 
represent the XRD reference for Paratacamite (Cu2Cl(OH)3) and the blue ones for Halite (NaCl). 
      Paratacamite – Cu2Cl(OH)3 
      Halite - NaCl 
Fig. 58 – Zeta potential distribution at pH 6.5 during the synthesis of copper oxo-hydroxide ([Cu]=20 mM) in the 
presence of carnitine (20 mM). 
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Next, in order to try to further disperse the copper particles with carnitine, a higher 
concentration of carnitine was tested. Thus, 40 mM of copper (II) and 120 mM of carnitine 
were used, following the same method. However, a polydisperse population of large 
particles was still obtained (Fig. 62), and it was concluded that with this method the use of 
this ligand alone is not a good option for the production of copper nanoparticles in water. 
 
 
 
 
 
 
 
 
 
 
 
Tartaric acid used previously shown to be a good dispersive ligand for copper oxo-
hydroxides [77]. Therefore, this ligand was used in combination with carnitine. Here a 
solution of 40 mM of copper (II), 20 mM of carnitine, and 20 mM of tartaric acid was 
prepared and NaOH was added to it. At pH 5 the average particle size of is 0.7 nm 
Fig. 62 - Particle size distribution at pH 7 during the synthesis of copper oxo-hydroxide ([Cu]=40 mM) in the 
presence of carnitine (120 mM). 
Fig. 61 – Inhibition of growth of E. coli by CuOH Car 
nanoparticles at 6h, 100 ppm of copper, and 10
-2 
bacterial dilution. The white column represents the 
results for control (40 mM solution of copper 
chloride) and the grey one for the suspension.  
Fig. 60 - Copper phase distribution (%) of CuOH Car 
diluted in broth at concentrations 1, 10 and 104 ppm. 
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(Fig.  63A). At pH 6, there was a substantial precipitation and all particles had a size higher 
than 1000 nm (Fig. 63B). This agglomeration was probably due to charge neutralization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2. ZINC 
 
Zinc, like copper, acts as a Lewis acid, being an electron pair acceptor. Thus, when 
zinc (II) chloride (ZnCl2) is dissolved in water the resulting solution has a low pH:  
 
            
                         (5) 
        
                      
      
  (6) 
                    
As a control experiment for the production of unmodified zinc oxo-hydroxides, the pH 
of a zinc solution (40 mM) was gradually increased with NaOH. Initially, zinc remained 
soluble but as the pH was raised (>pH7), a white precipitate started to form (Fig. 64). This 
precipitation is due to the formation of unmodified zinc oxo-hydroxide particles, which are 
insoluble. These particles were characterized by XRD (Fig. 65). The identified peaks 
matched the XRD pattern for halite (NaCl). The remaining peaks were also compared to the 
Fig. 63 - Particle size distribution at various pH‟s during the synthesis of copper oxo-hydroxide ([Cu]=40 mM) in 
the presence of carnitine (20 mM) and tartaric acid (20 mM). (A) pH 5; (B) pH 6. 
 
A – pH 5  
B – pH 6  
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pattern for several zinc hydroxide mineral phases (ashoverite, sweetite, and wulfingite), but 
they did not match any of those. Thus, it was not possible to determine the mineral phase of 
these particles. In comparison to the curve of the synthesis of unmodified copper oxo-
hydroxide particles (Fig. 14), the precipitation of zinc occurs for a much higher pH. This may 
result on the production of nanoparticles for only high pHs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 64 – Zinc phase distribution (%) with varying pH during the synthesis of zinc oxo-hydroxide ([Zn]=40 mM). 
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Fig. 65 – XRD characterization of unmodified zinc oxo-hydroxide particles. The peaks in blue represent the XRD 
pattern for Halite (NaCl). 
      Halite - NaCl 
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4.2.1. Zinc nanoparticles 
 
Cysteine allowed the production of copper nanoparticles at higher pH and has also 
affinity for zinc. This amino acid was used for the production of zinc nanoparticles. Firstly the 
pH of an equimolar (40 mM) solution of zinc (II) and cysteine was gradually increased. The 
zinc phase distribution during the synthesis is shown in Fig. 66. There was substancial 
precipitation at pH 5. The agglomeration occurred for a lower pH than for unmodified zinc 
oxo-hydroxide (Fig. 64). Only a small amount of nanoparticles was obtained and the highest 
amount was obtained for pH 10.2 (30.1%). In this case, the cysteine did not have enough 
dispersive power and did not lead to a major production of nanoparticles. The use of a 
higher concentration of cysteine could lead to higher yield on the production of 
nanoparticles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus, a higher concentration of cysteine was used. A solution containing 40 mM of 
zinc (II) and 60 mM of cysteine was prepared and the synthesis was carried out. From pH 4 
nanoparticles started to form (Fig. 67). The highest amount of nanoparticles was obtained at 
pH 6 (93.0%) The mean particle size of the particles at pH 7.6 was 0.9 nm (Fig. 68). These 
nanoparticles were further characterized by XRD (Fig. 69). Also in this case, only halite was 
identified. The remaining peaks were also compared to the XRD pattern for several zinc 
hydroxide mineral phases (ashoverite, sweetite, and wulfingite), but they did not match any 
of those. However, there is a difference when comparing to the spectrum obtained for the 
unmodified particles (Fig. 65); the unidentified peaks are more defined than for the 
naniparticulate ones. Perhaps also in this case an amorphous material was obtained. When 
tested against E. coli, these nanoparticles showed not to have antimicrobial activity. Instead 
Fig. 66 – Zinc phase distribution (%) with varying pH during the synthesis of zinc (II) oxo-hydroxide ([Zn]=40 
mM) in the presence of cysteine (40 mM). 
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of inhibiting the bacterial growth, these nanoparticles led to an increase of 7.7% of the 
bacterial growth (Fig. 70). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 68 - Particle size distribution at pH 7.6 during the synthesis of zinc (II) oxo-hydroxide ([Cu]=40 mM) in the 
presence of cysteine (60 mM). 
Fig. 67 – Zinc phase distribution (%) with varying pH during the synthesis of zinc (II) oxo-hydroxide 
nanoparticles ([Zn]=40 mM) in the presence of cysteine (60mM). 
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Fig. 69 – XRD characterization of ZnOH Cys nanoparticles. The lines in red represent the XRD reference for 
Halite (NaCl). 
      Halite - NaCl 
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Tartaric acid was also used again to further disperse the particles produced with an 
equimolar solution of zinc and cysteine. Therefore, part of the cysteine used before was 
substituted by tartaric acid and a solution containing 40 mM of zinc (II) and 20 mM of 
cysteine and tartaric acid was used for this synthesis. The agglomeration started at pH 5.0 
and from this pH on it kept rising until pH 7.0 (Fig. 71). At pH 8.1, nanoparticles were 
produced and the precipitated zinc decreased. The highest amount of nanoparticles was 
obtained at pH (33.5%). Even at this pH, there was still a high amount of precipitate. Thus, 
this synthesis did not result in satisfactory yield of production of nanoparticles. 
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Fig. 71 – Zinc phase distribution (%) with varying pH during the synthesis of zinc (II) oxo-hydroxide 
nanoparticles ([Zn]=40 mM) in the presence of cysteine (20mM) and tartaric acid (20mM). 
Fig. 70 – Inhibition of growth of E. coli by ZnOH Cys 
nanoparticles at 6h, 100 ppm of copper, and 10
-2 
bacterial dilution. The white column represents the 
results for control (40 mM solution of zinc chloride) 
and the grey one for the suspension.  
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4.3. EFFECT OF AQUEOUS RESUSPENSION OF NANOPARTICLES 
 
Throughout this project, a major problem has been the partial dissolution of the 
nanoparticles when diluted in broth, the bacterial culture medium used in the antibacterial 
activity tests. However, it was not known if this dissolution was due to the dilution of the 
suspension, i.e. to a lower concentration of the particles. So, in order to clarify this, a powder 
obtained from a sub-micron suspension was resuspended at around the same concentration 
in water and in broth (4 mM). This should show whether the dissolution of particles is due to 
dilution or to the composition of the broth. The resulting copper phase distribution is shown 
in Fig. 72. Whilst the suspension remained mostly agglomerated in water, the same was not 
verified in broth. In fact, in broth most of the copper solubilised (59.6%) and a part of it 
turned nanoparticulate (40.4%). This shows that the solubilisation of the particles in broth is 
not due to the dilution factor, but it is probably due to the presence of certain ligands which 
further disperse the particles. 
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Fig. 72 - Copper phase distribution (%) resulted from 
the resuspension of a material obtained from a sub-
micron particle containing suspension in water and 
broth at 4 mM. 
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5. CONCLUSION 
 
A summary of the most important results obtained during this project is present in 
Table 1. 
Copper oxo-hydroxide nanoparticles were produced using a different ligand, 
glucuronic acid, in combination with a ligand previously used, tartaric acid. The obtained 
nanoparticles presented the same limitations as in previous work as they partly solubilised 
when diluted in broth. So, in order to increase the stability of the nanoparticles, a different 
salt was used. The aim of this synthesis was to produce copper oxo-hydroxide nanoparticles 
of a different mineral phase other than paratacamite, using tartaric acid and adipic acid as 
ligands. This strategy proved successful and the mineral phase of the unmodified particles 
was copper (II) hydroxide. The mineral phase of the nanoparticles was not identified but 
most likely consisted of an amorphous phase related to the parent mineral, i.e. copper (II) 
hydroxide. However, there was not an improvement in antimicrobial activity and the 
nanoparticles showed to have limited action in the inhibition of the bacterial growth. Next, 
synthesis methods for copper oxides, which should be more stable than copper oxo-
hydroxides, were developed. The method used displayed efficacy on the production of 
copper oxides. Although a higher stability seems to have been achieved, the nanoparticles 
showed to have even less antibacterial activity than the control. Nanoparticles of a different 
mineral phase, i.e. copper phosphates, were also obtained using citric acid as ligand. The 
stability of these nanoparticles was not improved but they did show higher antibacterial 
activity (68.6%), the best one obtained so far. However, these results are still not ideal. Next, 
attempts were made to produce copper nanoparticles using micelles, but only large particles 
were obtained. For a higher interaction between nanoparticle and the bacterium cell wall, 
positively charged sub-micron particles were produced using carnitine. The mineral phase of 
these particles was paratacamite, which may indicate that the ligand forms a coating instead 
of intercalate in the structure of the particles. The positive charge seems to have indeed 
resulted in a higher interaction between the particles and the bacterium, since that a higher 
antibacterial activity was also obtained (68%). However, improvements have still to be made, 
since that this inhibition of bacterial growth is still not completely satisfactory. 
Zinc nanoparticles were produced using cysteine as ligand. It was already expected 
that these nanoparticles would show less antibacterial activity than copper nanoparticles, but 
instead of inhibiting the bacterial growth they stimulated it. Perhaps this was due to cysteine 
leading to a lower interaction between nanoparticle and bacterium cell wall, since that the 
same problem was verified for the copper oxide nanoparticles produced with cysteine. Thus, 
further attempts should be made on the production of zinc nanoparticles. 
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Throughout this project, a major problem has been the instability of the nanoparticles 
when diluted in broth, the bacterial culture medium used. However, it was not known if this 
was due to the effect of dilution or to the composition of the broth. It was possibly to clarify 
this by resuspending a material obtained from a sub-micron suspension in both water and 
broth at the same concentration. The resulting phase distribution was completely different; in 
water, the particles remained sub-micron, whilst in broth a fraction was further dispersed and 
nanoparticles were formed and there was also partial dissolution. The instability of the 
particles in broth may be due to the presence of certain ligands that further disperse them. 
 
 
Table 1 – Summary of key results. 
Suspension2 Nano. Mineral phase Hydrodynamic 
size 
(nm) 
Nano. 
fraction 
in broth 
Bacterial 
growth 
inhibition 
CuOH No Paratacamite - - - 
CuOH Glr No - - - - 
CuOH TartGlr Yes - 1.4 ± 0.3 
(pH 6) 
2.6 ± 0.2 
(pH 10) 
46% 57.8% 
CuOH (acetate) No Copper (II) hydroxide 
(Cu(OH)2) 
- - - 
CuOH TartAd 
(acetate) 
Yes Sodium acetate hydrate 
(C2H3NaO2·3H2O) and 
unidentified peaks 
1.9 ± 0.4 
(pH 7)  
3.6 ± 0.3 
(pH 8) 
- 56.1% 
CuO No Tenorite - - - 
CuO Tart No Tenorite - - - 
CuO Cys Yes - - 61% 16.3% 
CuPO4 No Copper hydrogen phosphate 
hydrate (Cu4H(PO4)3·3H2O and 
CuHPO4·H2O) 
- - - 
CuPO4 Cit Yes Unidentified 1.0 ± 0.3 
 (pH 6) 
49% 68.5% 
CuOH SDS No - >100 - - 
CuOH SDSC18TAB No - >>100 - - 
CuOH TartC18TAB No - >>100 - - 
CuOH Car No Paratacamite 124 ± 1.5 40% 68.1% 
ZnOH No Unidentified - - - 
ZnOH Cys Yes Unidentified 0.90 ± 0.01  - -7.7% 
 
 
                                               
2
 This is an internal nomenclature, as the exact compositional formula was not determined. 
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6. FUTURE WORK 
 
Copper (II) carbonates nanoparticles were synthesised. However, they were still not 
tested due to the lack of time. Thus, for future work, the antibacterial activity of these 
nanoparticles should be tested and further characterisation should be carried out, namely, 
XRD characterisation. 
A different approach to the general method used in this project should also be made, 
since that all the nanoparticles so far partly dissolve when diluted in broth. This medium can 
be seen as a model for what happens in physiological conditions, since its composition is 
more similar to the one of physiological liquids than water. Thus, this dissolution can also 
occur once these nanoparticles are biologically applied. In order to obtain more stable 
nanoparticles in broth, modifications to some of the best results obtained during this project 
can be made (to produce carnitine coated oxides, other oxo-phophates, etc.). Another 
possible strategy is to produce large particles in water and then study them when diluted in 
broth. Also, particles that were excluded during this project due to their large size should be 
further tested, since they can became nanoparticulate when diluted in broth. 
Further attempts should be made on the synthesis of zinc nanoparticles and, if a 
satisfactory antimicrobial activity is obtained, they could be used in a mixture of copper and 
zinc nanoparticles, in order to obtain even higher antimicrobial activity. 
To further characterize the composition of the nanoparticles that presented the best 
results, using other techniques, such as scanning transmission electron microscopy (STEM) 
and Fourier transform infra-red (FTIR). 
The nanoparticles should also be tested in other strains of bacteria, since that some 
nanoparticles may not have great effect on E. coli but can have a better one in other strains. 
This could be done by starting to test them also on a gram-positive bacterium, such as 
Pseudomonas aeruginosa, since that till now only a gram-negative bacterium was tested. If 
possible, they should also be tested against bacteria with resistance to antibiotics. 
Subsequently, these nanoparticles could also be tested against other microorganisms. 
The aim of this project is to produce safe nanoparticles that present antimicrobial 
activity. Thus, in case a suspension has an effective antimicrobial activity, the cytotoxicity for 
human cells of the nanoparticles should also be tested. This is an important step, since that 
the nanoparticles can be effective as antimicrobials but also prejudicial for human cells, not 
making them suitable for application. 
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APPENDICES 
 
1. ICP-OES CALIBRATION CURVE 
 
This is an example of a calibration curve obtained during an ICP-OES analysis. The 
calibration consists of 8 different standards of copper or zinc, where the lowest has 0 ppm 
and the highest 100 ppm. In this case, during the analysis 4 calibrations were made: one at 
the beginning, another at the end and the other two in between. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. GROWTH INHIBITION 
 
Here an example of the results obtained for the OD variation with time for the 
different amounts of bacteria used is given. 
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Fig. 73 – Calibration curves obtained during an analysis by ICP-OES. Four calibrations were made at 
different points. 
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Fig. 74 – Evolution of optical density with time during a test for the determination of the 
antibacterial activity of copper nanoparticles with 10
-5
 bacterial dilution. 
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Fig. 75 - Evolution of optical density with time during a test for the determination of the 
antibacterial activity of copper nanoparticles with 10
-4
 bacterial dilution. 
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Fig. 76 - Evolution of optical density with time during a test for the determination of the 
antibacterial activity of copper nanoparticles with 10
-3
 bacterial dilution. 
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Fig. 77 - Evolution of optical density with time during a test for the determination of the 
antibacterial activity of copper nanoparticles with 10
-2
 bacterial dilution. 
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Fig. 78 - Evolution of optical density with time during a test for the determination of the 
antibacterial activity of copper nanoparticles with 10
-1
 bacterial dilution. 
